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ABSTRACT
BOVINE ENTEROPATHOGENIC CORONAVIRUS: THE EFFECT
OF THE HOST CELL AND TRYPSIN MODIFICATION ON THE VIRUS 
STRUCTURE, CYTOPATHIC EXPRESSION, AND INFECTIVITY
by
Karen St. Cyr-Coats
Human rectal tumor-18 (HRT-18) cell clones 3F3, 3E3, D2, and 4B3 
exhibited differences in cellular morphology in Giemsa-stained cultures 
and developing monolayers. Differences were evident in growth kinetics 
and plating efficiency of each clone. The clones produced colonies in 
soft agar, demonstrating anchorage independence. Cytopathic expression 
(CPE) including cytoplasmic vacuolization and cell fusion occurred in
BCV-L9-infected clones 3F3, D2, and 3E3. Cell fusion was inapparent in
clone 4B3.
Bovine coronavirus strain L9 (BCV-L9) and 5 wild-type isolates
replicated in HRT-18 cells, inducing cell fusion. Strain L9,
exclusively, replicated in D2BFS cells, requiring trypsin to induce cell 
fusion. Strain L9 produced plaques in the HRT-18 clones, but the ease 
of plaque formation and plaque morphology was host cell dependent. Host 
cell- dependent plaque formation was demonstrated by wild-type BCV 
strains, and plaque morphology was strain dependent. The intensity of
xiv
trypsin enhancement of CPE and plaque development depended on the virus 
strain and host cell.
Trypsin greatly enhanced the infectivity of BCV-L9 in D2BFS and 
HRT-18 cells, and to lesser extents in clones 3F3, 3E3, and D2. 
Trypsin-enhanced infectivity was not detected in clone 4B3. The 
infectivity of strain LY-138 in HRT-18 cells was slightly enhanced by 
trypsin.
Eleven structural proteins of BCV-L9 were detected by 
immunoblot ting, including 185, 160, 140, 125, 110, 100, 52, 46, 37, 
31-34, and 26-28 Kd species. Under reducing conditions 185, 140, and 
100 Kd species migrated as 190, 65, and 95 Kd forms. Silver-stained 
proteins of 18, 20, and 23 Kd were reduced to a 20-23 Kd cluster.
Host cell-dependent differences in the protein profile of L9 were 
detected. A 62 Kd protein was specific to L9 (D2BFS with trypsin). L9 
(4B3) and L9 (D2) lacked the 46 and 110 Kd bands, respectively.
Cleavage of the 185 Kd protein, an increase in the 100 Kd band, and 
conversion of the 31-34 Kd cluster to a 34 Kd band occurred when BCV-L9 
was propagated in D2BFS cells with trypsin. Trypsin converted the 
reduced, 95 Kd protein found in L9 (HRT-18) to 90 Kd, and the 20-23 Kd 
cluster was altered to 19-23 Kd. In vitro trypsin treatment of L9 (3F3) 
resulted j'.n cleavage of the 46 Kd molecule and the appearance of a 25 Kd 
species.
xv
CHAPTER I. INTRODUCTION
Bovine enteropathogenic coronavirus (BCV), a member of the family 
Coronaviridae, is a major cause of gastroenteritis in newborn calves.
The virus induces a severe diarrhea with dehydration and malabsorption 
resulting from destruction of villous enterocytes of the small intestine 
and colon (3,32,85). The high morbidity and mortality rate associated 
with this disease makes it of significant economic importance in the 
cattle industries (7,14).
Factors affecting the virulence of BCV are largely undefined.
Study of the virus was hampered by the difficulty of propagating the 
virus in culture. The inclusion of trypsin in culture medium has aided 
in the propagation of virus. Trypsin enhances the replication, 
cell-fusing activity, and plaque development of many BCV strains 
(97,124,135). Some viral proteins are altered in their electrophoretic 
mobility following trypsin treatment (133).
The effect of trypsin on the infectivity of the virus has not been 
clearly defined. Trypsin and other proteases are normally found in the 
intestine - the site of coronavirus replication in the natural 
infection. Therefore, this enzyme may influence the virulence of the 
virus in the natural host.
In 1974 Tompkins and coworkers (122) established the human rectal 
turaor-18 (HRT-18) cell line from an adenocarcinoma of the lower 
gastrointestinal tract. These cells are permissive to many BCV strains, 
greatly improving in vitro culture methods for the virus.
Immunofluorescent examination of plaques formed by BCV in HRT-18 
monolayers reveals that not all of the cells express viral antigen.
1
2This finding indicates that subpopulations of HRT-18 cells may exist 
which differ in susceptibility to BCV.
The replication and cytopathic effects of coronaviruses are highly 
dependent on both the host cell type and the virus strain.
Host-dependent differences in proteolytic processing have been reported 
for mouse hepatitis virus strain A59 (MHV-A59) when the virus was 
propagated in different murine cell lines (37,117). Cleavage of the 180 
Kd peplomeric protein contributes to activation of cell fusion (37). 
Proteolytic processing is necessary for activating cell-fusing activity 
and infectivity of both orthomyxoviruses and paramyxoviruses, as well as 
a number of other viruses (24,25,39,51-54,92,93,98,99,106).
I.A. STATEMENT OF RESEARCH PROBLEM
HRT-18 cells consist of heterogeneous cell types which differ in 
BCV susceptibility. Four HRT-18 cell clones were established by 
limiting dilution in hopes of selecting cell types which were refractory 
or varied in susceptibility to the virus. To assess putative 
differences between the clones, it was necessary to characterize their 
susceptibility to BCV infection and the growth properties of each clone. 
Both host cell-dependent factors and the strain of virus affect 
coronavirus replication in culture (37,47). The influence of the host 
cell, virus strain, and trypsin modification on BCV cytopathic 
expression was examined. Additionally, the effect of trypsin on BCV 
infectivity was explored. Activation of cell-fusing activity of MHV is 
dependent on cleavage of the E2 glycoprotein. The extent of protein 
processing varies between cell types (37,117). Host cell-dependent
3differences in the processing of structural proteins were suspected for 
BCV and were examined in this study.
I.B. OBJECTIVES
The following objectives were derived from the research problem.
1 - To characterize the HRT-18 clones
a - Determine the cytopathogenicity of BCV in each clone, 
b - Characterize the clones based on morphology, growth kinetics, 
plating efficiency, and growth in soft agar.
2 - To determine the effect of virus strain, host cell, and trypsin on
BCV-induced cytopathic expression and plaque formation.
3 - To assess the effect of trypsin on BCV infectivity.
4 - To analyze the polypeptide profiles of BCV propagated in different
cell types.
a - Assess differences in profiles, 
b - Examine the effect of trypsin on profiles, 
c - Correlate virus proteins to cell fusion.
The investigations designed to accomplish each objective were 
written as individual manuscripts suitable for submission as journal 
articles. They are entitled:
1. "Characterization of Specific Properties of HRT-18 Cell Clones:
Cell Morphology, Growth Kinetics, Plating Efficiencies, and 
Expression of Bovine Coronavirus." Submitted to In Vitro. 
Co-authored by G.F. Amborski, M.J. Newman and J. Storz.
2. "The Influence of the Host Cell, Virus Strain, and Trypsin 
Modification on Bovine Coronavirus Cytopathic Expression and Plaque
4Formation." Submitted to Journal of Veterinary Medicine.
Co-authored by J. Storz.
3. "The Influence of the Host Cell and Trypsin Treatment on Bovine 
Coronavirus Infectivity". Submitted to Journal of Veterinary 
Medicine. Co-authored by H.R. Payne and J. Storz.
4. "The Effect of the Host Cell and Trypsin Treatment on the Structural 
Proteins of Bovine Coronavirus Strain L9." Submitted to Archives of 
Virology. Co-authored by K. Hussain, R.L. Schnorr, and J. Storz.
CHAPTER II. REVIEW OF PERTINENT LITERATURE
II.A. COMPARATIVE ASPECTS OF CORONAVIRUS PROPERTIES
II.A.I. Classification and Morphology
Coronaviruses are members of the family Coronaviridae, comprised of 
the single genus Coronavirus. Originally, this family was recognized 
based on the unique morphology of the virus - spikes or peplomers formed 
by surface glycoproteins extend from the virion, giving it the 
appearance of a "corona" (47,125). The family is now recognized for its 
distinct physical, chemical, and antigenic properties (83).
Coronaviruses are positive-stranded RNA viruses. The virions are 
spherical to pleomorphic with a diameter of 80-220 nra. These viruses 
are enveloped with a lipoprotein membrane which is obtained as the virus 
buds through intracellular membranes (47).
II.A.2. Structural Proteins
The number of structural proteins comprising the virion of different 
coronaviruses is shown in Table 1.1. The best studied coronavirus is 
mouse hepatitis virus (MHV) strain A59. For many years this virus was 
thought to consist of three structural proteins: El (23 kilodaltons) -
the matrix glycoprotein, E2 (180 Kd) - the peplomeric glycoprotein, and 
N (50 Kd) - a phosphoprotein forming the nucleocapsid (115). Recently, 
Sturman and coworkers (119) demonstrated that the 180 Kd protein 
consists of a dimer of two 90 Kd polypeptides, separable by 
hydroxyapatite chromatography and consisting of different peptides upon 
limited protease digestion. Robbins and coworkers (101) identified a 
140 Kd protein from MHV virions and infected cells which is an RNA 
binding protein. This protein is reduceable to 50 Kd products, and is
5
6antigenically related to the nucleocapsid. The protein is probably a 
multimeric form of the nucleocapsid protein.
Six polypeptides comprise the MHV strain JHM virion. A group of 
three glycoproteins ranging in molecular weight from 97.5 Kd to 170 Kd 
form the peplomers. A 60.8 Kd protein most likely serves as 
nucleocapsid, and a 22.7 Kd protein and a 24.8 Kd glycoprotein are 
located in the lipid bilayer (128).
Diarrhea virus of infant mice (DVIM) is a newly isolated 
coronavirus. Sugiyama et al (120) have identified four structural 
proteins associated with this virus consisting of three glycoproteins - 
gp 180 Kd, gp 69 Kd, gp 25 Kd, and a 58 Kd protein. A 140 Kd
glycoprotein formed by two identical molecules of gp 69 is evident under
non-reducing conditions.
The polypeptide profiles of coronaviruses associated with 
respiratory and enteric infections of humans was determined. HCV-229E 
is a respiratory pathogen comprised of 3 major polypeptides: a 180 Kd
gp, a 50 Kd phosphoprotein, and a 21-25 Kd gp family, as well as 3 minor 
proteins of 107 Kd, 92 Kd, and 39 Kd (62). The respiratory pathogen HCV 
0C43 is made up of 4 major proteins - gp 190 Kd, gp 130 Kd (a disulfide-
linked dimer of 65 Kd), pp 55 Kd, and a glycoprotein cluster at 26 Kd
(46). The newly identified human enteric coronaviruses (HECV) 24 and 35 
show major protein bands at 62 Kd, 60 Kd, 34 Kd, and 32 Kd and 5 minor 
bands ranging from 56-110 Kd (5). Human enteric coronavirus 14 consists 
of 5 major proteins with molecular weights within the range of 190-23 Kd 
(100).
Of particular interest is the polypeptide composition of bovine 
coronaviruses. Discrepancies exist about the number of structural
7proteins forming this virus, indicating that virus strain, cultural 
conditions, and/or purification schemes may affect the number of protein 
bands obtained by polyacrylamide gel electrophoresis. In 1979 Hajer and 
Storz (42) reported 7-10 structural proteins for BCV strain LY-138, a 
field isolate purified from diarrhea fluid. These proteins included gp 
110, gp 100, p 82, p 70, gp 53, gp 45, and p 36. Williams and Storz 
(133) identified two forms of BCV strain L9 from isopycnic CsCl
3gradients. These virions had densities of 1.223 and 1.255 g/cm and 
exhibited different polypeptides profiles. Common to both types were 
polypeptides of 53 Kd, 47 Kd, 35 Kd, and a 22-26 Kd pentacluster. Light 
virions had additional bands at 182 Kd, 109 Kd, and 20 Kd, while dense 
virions had unique proteins of 172 Kd, 95 Kd, 21 Kd, and 15 Kd.
Other investigators reported fewer proteins associated with the 
virion of BCV-L9. King and Brian (63) described 5 proteins comprising 
the virus: glycoprotein 140 which is a disulfide-linked dimer of 65 Kd
subunits, gps 120, 100, and 26 Kd and a 52 Kd phosphoprotein. Hogue, 
King and Brian (46) identified a 190 Kd glycoprotein which was normally 
present as 120 Kd and 100 Kd subunits. Using pronase and bromelain 
digestion, King and coworkers (64) determined that gp 140, 120, and 100 
are surface proteins with gp 140 serving as viral hemagglutinin. Using 
monoclonal antibody reactivity to BCV G110 surface proteins, Vautherot 
and other investigators (126) showed that a 105 Kd glycoprotein was 
important in virus-cell interactions and hemagglutination. The profiles 
of a wild-type BCV isolate (BECV-WS) and a cell-adapted strain 
(BECV-F15) were compared by Laporte and Babulesco (71). They found very 
similar protein compositions for the two viruses with polypeptide bands 
at 125 Kd, 65 Kd, 50 Kd (major protein), 45 Kd, 36 Kd, and 28 Kd.
8The structural proteins associated with other mammalian 
coronaviruses was evaluated. The composition of a rabbit enteric 
coronavirus was examined by Descoteaux and coworkers (31). They found 8 
structural proteins - 7 associated with the envelope with molecular 
weights ranging from 100 Kd-34 Kd and a single nucleocapsid protein of 
54 Kd.
The porcine coronavirus of transmissible gastroenteritis (TGEV) 
reportedly consists of 4 major proteins - gp 200 (surface protein), gp 
30, gp 28.5, and vp 50. Two minor proteins of 105 and 80.5 Kd comprise 
the 200 Kd protein (41). Hemagglutinating encephalomyelitis virus 
(HEV), a cause of porcine vomiting and wasting disease, is composed of 8 
structural proteins with molecular weights ranging from 180-31 Kd. The
surface projections are formed by gps 180, 130, and 75, with gp 76
serving as viral hemagglutinin. Glycoproteins 31 Kd and 32 Kd are 
membrane associated. A 64 Kd protein is the only nonglycosylated 
protein (17).
Garwes (40) determined the polypeptide structure of canine 
coronavirus, an enteric pathogen antigenically and structurally related 
to TGEV. The virus has 4 structural proteins - gp 204, p 50, gp 32, and 
gp 22.
Coronaviruses causing feline peritonitis and gastroenteritis have 
been identified. Boyle and investigators (9) demonstrated three major 
proteins comprising these viruses. A 45 Kd protein forms the
nucleocapsid; a 210 Kd protein is the peplomeric protein; and a 27-33 Kd
cluster is the matrix protein. A minor protein of 42 Kd is also 
associated with feline coronavirus.
9Infectious bronchitis virus (IBV), an avian coronavirus, was once 
considered to be more complex than mammalian coronaviruses with reports 
of 7-16 structural proteins (73,111). However, MacNaughton and Madge 
(78) discovered that additional protein bands on SDS-PAGE gels were a 
result of harsh treatment during virus preparation. Cavanagh (18,19,20) 
reported 3 major proteins for IBV. Sq is a surface protein precursor 
which is cleaved to (gp 90 Kd) and S£ (gp 84 Kd). The matrix protein 
is composed of glycosylation isomers of 23-34 Kd, and N (nucleocapsid) 
has a molecular weight of 50-54 Kd. Urea treatment of IBV virions 
revealed that is responsible for viral infectivity and 
hemagglutinating activity, but not attachment to susceptible cells.
This molecule also elicits antibodies which cause virus neutralization 
and hemagglutination inhibition (21,22).
II.A.3. Non-structural Proteins
Very little is known about the structure and function of the 
coronavirus non-structural proteins. Most likely they function in 
regulation of replication and transcription of the virus. Messenger RNA 
1, a genome length transcript, codes for the 200 Kd viral RNA-dependent 
RNA polymerase. Two other non-structural proteins of 30 Kd and 14-17 
Kd, coded for by mRNAs 2 and 5, respectively, have been identified, but 
the function of these is unknown (66,80). Budzilowicz and Weiss (12) 
sequenced the nucleotides of MHV A59 mRNA 5 - a nonstructural gene. Two 
open reading frames (ORF) coding for two non-structural proteins were 
identified. One ORF codes for a 13 Kd protein which is rich in basic 
amino acids and possibly serves as an RNA binding protein. The other 
ORF codes for a 9.6 Kd protein containing a long stretch of hydrophobic
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amino acids. This protein may function in the association of viral 
polymerase complexes with membranes.
II.A.4. The Glycosylation Process
The number and sizes of the glycoproteins associated with 
coronaviruses is different, but those associated with MHV are well 
characterized according to structure and function. A 20-30 Kd 
transmembrane glycoprotein (El) forms the matrix of the MHV virion.
Using dog pancreatic microsomes, Rottier and coworkers (103) determined 
that the protein is primarily located within the membrane with only 
small portions of the amine and carboxy termini protruding from the 
membrane. The protein has no cleavable membrane insertion sequence. 
Instead, three hydrophobic regions of approximately 20 amino acids each 
are located within the protein at positions 27-46, 57-77, and 82-102 
(56). The hydrophobic sequence located closest to the carboxy terminus 
serves as the signal sequence. This internal signal sequence requires 
signal recognition particle for proper membrane insertion (102). 
Glycosylation of El of murine and bovine coronaviruses is resistant to 
tunicamycin, indicating that sugar residues are linked via O-glycosidic 
bonds to serine or threonine residues with no involvement of 
dolichol-linked N-acetylglucosamine intermediates found in N-linked 
glycosylation (50,95). However, N-linked oligosaccharides are found on 
the El glycoprotein of IBV (112). Glycosylation of El does not occur in 
the rough endoplasmic reticulum, rather, the protein is most likely 
glycosylated as completed virions pass through the Golgi (103). Studies 
indicate that El probably directs budding of the virion through 
intracellular membranes. For example, Tooze et al (123) demonstrated
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the localization of El on membranes of the endoplasmic reticulum and 
Golgi, where budding occurs. Additionally, tunicamycin-treated cells 
which lacked E2 showed normal budding (49). El also interacts with the 
nucleocapsid, probably binding N to the viral envelope as it buds (118).
The number of glycoproteins comprising the coronavirus peplomer 
depends on the strain of virus. The peplomeric glycoprotein of MHV-A59 
(E2) has a molecular weight of 180 Kd and is comprised of two 90 Kd 
species, 90A and 90B, which are noncovalently associated and are 
separable by host protease or by trypsin cleavage. 90A is acylated with 
palmitic acid and is probably associated with the lipid bilayer. 90B is 
not acylated (119). The native 180 Kd molecule has one trypsin cleavage 
site, and intrachain disulfide bonding contributes to its conformation 
(115,116). Unlike the matrix glycoprotein, glycosylation of E2 is 
tunicamycin sensitive, involving en bloc transfer of oligosaccharides 
from a dolichol-linked N-acetylglucosaraine intermediate. The resulting 
linkage is N-glycosidic and occurs between N-acetylglucosamine and 
asparagine (95). This molecule can migrate to the plasma membrane 
rather than remaining localized at intracellular membranes (117).
Several biological activities are directly attributed to the peplomer. 
This molecule is responsible for binding the virus to cell receptors.
For example, decreased binding of virus to the cell occurred with virus 
which lacked peplomers (50). Monoclonal antibody directed against gp 
105 of BCV neutralized the virus and inhibited hemagglutination (126). 
Limited enzymatic digestion with pronase or urea demonstrated 
hemagglutinating activity of surface proteins of bovine and avian 
coronaviruses (21,64). Immunologically, E2 is responsible for induction 
of neutralizing antibody to the virus, and its presence on the cell
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surface elicits a cell-mediated response (26,43). Cell-fusing activity 
of MHV is attributed to E2. Using monoclonal antibody against E2 of 
MHV-JHM, Collins and others (26) inhibited cell fusion of L241 cells. 
Tunicamycin treatment of MHV-A59-infected 17C11 cells blocked 
glycosylation of E2 and prevented cell fusion (50). With MHV-A59, cell 
fusion is a result of cleavage of inactive 180 Kd protein into its 90 Kd 
subunits (37,119).
II.A.5. Antigenic Properties
Antigenically', coronaviruses can be divided into two main groups: 1
- avian strains and 2 - mammalian strains. The mammalian strains can be 
further subdivided (Table II.2) (77). Antigenic relatedness between 
strains was for the most part determined by immunofluorescence studies. 
Recent studies have focused on the cross reactivity of individual 
proteins. For example, Hogue et al (46) used antiserum against BCV 
structural proteins to assess cross reactivity of BCV-L9, MHV-A59, and 
HCV-0C43. HCV-OC43 was found to have four proteins which are 
antigenically homologous to BCV, while MHV-A59 had three antigenically- 
related proteins. Monoclonal antibodies were used by Snyder and 
Marquardt (108) to assess the antigenic relationships of IBV serotypes 
and Fleming et al (36) to assess antigenic relationships of murine 
coronaviruses.
II.B. UNIQUE FEATURES OF CORONAVIRUS REPLICATION
II.B.l. Attachment and Penetration
Attachment of coronaviruses to the receptors of susceptible cells 
occurs via the peplomers (21,50,64,126). The nature of the coronavirus 
receptor is unknown. Boyle, Weismiller, and Holmes are attempting to
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clone the MHV receptor gene (Mhv-1) from susceptible mice (8). The 
internalization process used by this virus is undetermined, but must 
occur either by fusion of the viral envelope to the plasma membrane or 
by endocytosis followed by fusion with an endocytic vesicle (47).
II.B.2. Coronavirus Genetic System and Its Replication
The coronavirus genome consists of positive-stranded RNA which is 
single-stranded, linear, and unsegmented. The genome is capped, 
polyadenylated, and infectious, making it capable of serving as 
messenger. The RNA has a molecular weight of 5.5 x 10^ daltons, 
consisting of 15,000-20,000 bases (47,110).
Following internalization and uncoating, genomic RNA serves as 
messenger for transcription of RNA-dependent RNA polymerase. This 
polymerase transcribes the genome into a full-length, negative-stranded 
replicative form, which serves as a template for mRNA transcription and 
synthesis of genomic RNA (83). Different polymerases are used for 
synthesis of mRNA and genome RNA. Replication of genomic RNA from the 
replicative form proceeds by a discontinuous or "stop and go" mechanism. 
This mechanism was suggested by the discovery of many small leader- 
containing RNA species whose size corresponded to lengths between the 5' 
end and probable hairpin loops of genome RNA. These small RNA species 
were thought to be pausing intermediates (66). The first demonstration 
of recombination between the genomes of murine coronaviruses A59 and JHM 
was reported in 1985 (68). Makino and coworkers (81) have since 
demonstrated high frequency recombination between different strains of 
murine viruses. Since the genome of coronaviruses is non-segmented, 
this finding suggests that segmented RNA intermediates might be
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generated and supports the discontinuous model. The discontinuous mode 
of replication has also been shown to occur in QB, MS2, and T2 phages 
(61,87).
II.B.3. Transcription and mRNA Properties
Coronavirus mRNA consists of a "nested set" of six subgenomic and 1 
genome-sized mRNA molecules. The mRNAs share common 3' ends, but differ
in length toward the 5' end. The mRNAs are functional - each is capped,
polyadenylated, and associated with polysomes. One protein is coded for 
by each mRNA - the translated sequence is found in the 5' region not
contained in the next smaller mRNA species. The protein product
translated from each mRNA has been defined as follows for MHV and TGEV: 
mRNA 1 - genome length - polymerase
mRNA 2 - non-structural protein
mRNA 3 - E2
mRNA 4 - non-structural protein
mRNA 5 - non-structural protein
mRNA 6 - El
mRNA 7 - N
These mRNAs are produced in non-equimolar amounts, but in constant 
proportions. The 5' ends of the genome and all mRNAs are identical,
consisting of a cap structure and 50-70 identical nucleotides
(58,64,69,110).
The fact that the leader and translated sequences of mRNAs are 
discontinuous on the genome has led to speculation about the mechanism 
of transcription. UV transcription mapping showed that target sizes for 
UV inactivation were identical to the physical sizes of mRNAs.
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Therefore, transcription does not involve processing of larger RNAs 
(59). In 1983 Spaan and investigators (110) proposed a polymerase-jump 
mechanism involving synthesis of short RNA transcripts from the 3' end 
of the negative-stranded RNA and translocation of the polymerase-leader 
complex to internal positions on the template. More recently this 
mechanism has been termed "leader-primed transcription." Specifically, 
this model involves the transcription of leader RNA from the 3' end of 
negative-stranded template which dissociates from the template. This 
free leader RNA binds to intragenic regions with homologous sequences on 
the RNA template. Leader RNA is cleaved at mismatched points generating 
a primer for initiation of mRNA transcription. Therefore, the 
leader-body fusion site varies for each mRNA species, according to the 
location of mismatched nucleotides. A regulatory mechanism for 
controlling the synthesis of RNA in infected cells may be the number of 
homologous nucleotides found at the intragenic sites preceding each mRNA 
(66).
"Leader-primed transcription" is supported by several studies, a) 
Leader RNAs of 50-90 nucleotides have been found in the cytoplasm of MHV 
cells (4) b) Budzilowicz et al (13) found three intragenic regions of 
MHV genome RNA with sequences common to the 3' end of mRNA leader 
sequences. These sequences may contain a binding site for hybridization 
of leader RNA to negative-stranded viral RNA at the beginning of each 
gene to prime synthesis, c) Leader RNAs separate from the RNA template, 
and ts mutants which produce leader RNA but not mRNA indicate that 
transcription of leader and mRNA are separate events (67). d) A high 
frequency of reassortment of leader sequences between coinfecting murine 
coronaviruses indicates a potential trans-acting property of leader RNA
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(82). Additionally, evidence for leader-primed transcription was shown 
with avian coronaviruses (11).
II.B.4. Role of Cellular Organelles in Assembly
Assembly of mammalian coronaviruses occurs in the cytoplasm of
infected cells. There is no involvement of the cell nucleus. Tooze and
coworkers (123) examined the replication and assembly of MHV in Sac-
cells using immunofluorescent analyses and electron microscopy. The 
3uptake of [ H] uridine in actinomycin D-treated cells revealed the 
synthesis of viral RNA within 4-5 hours post infection. Synthesis of 
the viral RNA occurs in the cytoplasm of infected cells (131).
Immunofluorescent analyses using polyclonal antibodies against disrupted 
whole virions and viral nucleocapsid (N) protein detected the presence 
of N within 4 hours post infection. The N protein is translated from 
the most abundant viral mRNA on free polysomes (104,123). N protein and 
newly synthesized genomic RNA associate in the cytoplasm to form a 
helical ribonucleoprotein. Translation of E2 occurred on the rough 
endoplasmic reticulum within 6 hours post infection. E2 is 
cotranslationally glycosylated via N-glycosidic linkages at asparagine 
residues, and core oligosaccharides are trimmed as the molecule passes 
through the Golgi. This protein is capable of migration to the plasma 
membrane (117). Translation of El was detected by immunofluorescence 
within 6 hours post infection in the rough endoplasmic reticulum. Using 
its internal insertion signal, the molecule is inserted into the 
membrane of the rough endoplasmic reticulum and transported to a smooth 
membrane perinuclear compartment where it is incorporated into virions. 
Intact virions are transported to the Golgi, where O-glycosylation of El
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occurs (56,103,123). Glycosylation of this protein does not involve the 
dolichol-linked N-acetylglucosamine intermediate. Rather, sugar 
moieties are linked at serine or threonine residues (94). El is not 
transported to the plasma membrane. The protein is confined to the 
intracellular membranes of the rough endoplasmic reticulum and Golgi, 
ant it only reaches the cell surface as a part of the mature virion. 
Budding occurs at sites where El accumulates, and is initiated when 
ribonucleoprotein recognizes the C-terminus of El projecting from 
intracytoplasmic membranes. Namely, budding in the smooth perinuclear 
vesicles and tubules located between the rough endoplasmic reticulum and 
Golgi was detected by EM within 6-7 hours post infection. At late 
stages of infection, El accumulated in the membranes of the rough 
endoplasmic reticulum, and budding occurred there (123). Doughri and 
coworkers (33) demonstrated that release of mature virions from the cell 
is a result of fusion of post-Golgi vesicles with the plasma membrane. 
This mechanism of release probably utilizes the host secretory 
apparatus.
Unlike mammalian coronaviruses, the replication of IBV is impaired 
in enucleated, UV irradiated, or a-amanitin treated cells, indicating 
the involvement of the cell nucleus and host transcriptional factors in 
virus replication (34). In addition, the El glycoprotein of IBV is 
glycosylated through N-glycosidic linkages (112). These differences 
between mammalian and avian coronaviruses suggest that the replication 
strategy of the two virus groups are different.
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II.C. EVIDENCE FOR PROCESSING OF CORONAVIRUS PROTEINS AND ACTIVATION OF 
CELL FUSION
In some cell culture systems coronaviruses are able to induce cell 
fusion. The relationship between induction of cell fusion and cleavage 
of viral proteins is of particular interest. The prototype virus, MHV, 
has provided much of the current knowledge in this area of study.
Using four different murine cell lines, Frana and coworkers (37), 
demonstrated that processing of the 180 Kd E2 glycoprotein of MHV-A59 to 
its 90 Kd subunits was host dependent. Different cells cleaved the 
precursor molecule to different extents and the cell-fusing activity of 
the virus correlated in part to the degree of proteolytic cleavage. For 
example, virions obtained from Sac- cells contained E2 which was 
completely cleaved to the 90 Kd form. These virions induced rapid cell 
fusion in L2 cells without requiring virus replication. In contrast, 
virions obtained from 17C11 cells had partially cleaved E2 and required 
trypsin for activation of rapid cell fusion.
The role of protease in MHV-induced cell fusion was also studied by 
Yoshikura and Tejima (135). Using a cold-sensitive plaque mutant, they 
showed that treatment of infected cells with trypsin enabled the mutant 
virus to form plaques consisting of fused cells on otherwise resistant 
cells, and allowed a virus which usually produced plaques consisting of
dead cells to form fusion plaques.
Storz and coworkers (114) found that cell fusion of BCV strain L9 
was enhanced in the presence of trypsin when the virus was grown in 
bovine fetal brain or bovine fetal thyroid cells. Cell fusion occurred
only minimally in thyroid cells and not at all in brain cells in the
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absence of trypsin, but fusion was apparent within 12 to 18 h post
infection when trypsin was present.
The protein(s) responsible for cell fusion are under investigation.
In 1982, the 170 Kd glycoprotein of MHV-JHM was identified as the viral
glycoprotein responsible for attachment and cell fusion. Sturraan and
investigators (119) demonstrated that the 180 Kd E2 glycoprotein of
MHV-A59 could be cleaved by trypsin or cellular proteases to two
different 90 Kd products, 90A and B, and consequently activate cell-
fusing activity of the virions. It is unknown which of the two species
mediates cell fusion, but the amino acid sequence at the new terminal
domains of the proteins is currently under investigation.
Electron microscopy of negatively-stained particles revealed that
BCV virions with shortened surface projections were produced in
trypsin-treated cultures (114). Williams and Storz (133) resolved two
BCV-L9 phenotypes in linear CsCl gradients. These had densities of
3
1.223 and 1.255 g/cm , but the relative proportion of dense virions 
increased in the presence of trypsin. The two virus phenotypes contained 
common polypeptides of 53, 47, 35, and 22-26 Kd pentacluster. Light 
virions contained additional proteins of 182, 109, and 20 Kd. 
Trypsin-dependent bands of 172, 95, 21, and 15 Kd were present in dense 
virions. The protein(s) responsible for BCV-induced cell fusion are 
undetermined.
The effect of trypsin on plaque development of BCV-L9 in bovine 
fetal brain and bovine fetal thyroid cells was examined (114). Plaque 
diameter was increased more than 5-fold when the enzyme was present in 
the overlay, and plaques were less turbid and more distinct. Plaque
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formation by many IBV strains in chicken embryo cell cultures required 
the presence of trypsin (97).
Toth (124) treated BCV-infected bovine embryonic lung cells with 
increasing concentrations of trypsin. He found that the viral 
infectivity, as well as the rate of replication was enhanced by trypsin 
in direct correlation with increases in trypsin concentration.
Indirectly, protease was shown to play a role in the production of 
human coronavirus. Appleyard and Tisdale (2) treated HCV strain 
229E-infected MRC-C cells with the protease inhibitor leupeptin. They 
found that the drug prevented multiplication of the virus if added 
within 2 h of infection, suggesting action at an early stage of 
replication. Frana and coworkers (37) also found that leupeptin delayed 
the onset of fusion in MHV-infected L2 cells by 4-6 hours and reduced 
the size of giant cells.
II.D. CYTOCIDAL ACTION OF CORONAVIRUSES IN BOVINE GASTROENTERITIS
Gastroenteritis is a major cause of morbidity and mortality in 
newborn animals. Numerous bacterial and viral agents cause this 
syndrome, but coronaviruses are a major cause of enteric infections in 
neonatal bovines. The high morbidity and mortality rate associated with 
the disease makes it one of economic significance in the cattle 
industries (7). Chronic shedding of coronavirus antigen-antibody 
complexes was demonstrated by ELISA in clinically normal cows, with 85 
of 121 cows (70%) responding positively. Shedding of the virus was 
found to be seasonal, with detectable virus occurring during the winter 
months (November to March), while no virus was detectable during summer
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months (July to September). Subclinical infections of adult cattle may 
serve as a source of infection for the neonate (27,29,30).
The high stability of the virus contributes to spread of infection, 
which occurs by ingestion of the agent. The proximal part of the small 
intestine is the first site of infection, followed by progression to the 
jejunum, ileum, and colon. The virus primarily attacks the 
differentiated absorptive epithelial cells and goblet cells of the 
villi, but there is some involvement of undifferentiated cells of the 
Crypts of Lieberkuhn and fibroblasts and endothelial cells of small 
blood capillaries of the lamina propria mucosae. Histologically, the 
most severe cytopathic changes occur in the proximal jejunum of the 
small intestine. Villi become broadened and shortened, fusion between 
adjacent villi occurs, with some denuding of the villi. Absorptive 
epithelial cells may become vacuolated and necrotic; goblet cells are 
reduced in number; and crypt epithelium becomes hyperplastic. The 
lamina propria mucosae may be edematous and infiltrated with mononuclear 
and polymorphonuclear cells. Distention of the smooth and rough 
endoplasmic reticulum and vesiculation of the Golgi occurs, and 
mitochondria swell, dilate, and decrease in number. Severe degeneration 
and necrosis of cellular organelles occurs, including ribsome depletion, 
distortion of mitochondrial cristae, and vacuolation of the cytoplasm. 
Fragmentation of the plasmalemma is apparent, and nuclei become pyknotic 
and lyse. Viral inclusions are evident in the cytoplasm.
As a result of the cytocidal action of bovine coronavirus in the 
intestine, a profuse, watery diarrhea develops. Fluid loss is due to an 
osmotic imbalance caused by undigested lactose in the lumen - a 
consequence of the loss of cells possessing disaccharidases and
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replacement of these mature cells by undifferentiated cells retaining 
secretory function. With the loss of mature enterocytes there is a 
decrease in the glucose,, sodium carrier and (Na+-K+) ATPase causing the 
loss of sodium, potassium, chloride, bicarbonate, and water. Depletion 
of bicarbonate causes acidosis which in turn contributes to K+-H+ ion 
exchange across cell membranes with a net loss of potassium from cells. 
Calves become hypoglycemic with inhibited gluconeogenesis and increased 
glycolysis. Death is often the result of severe diarrhea (3,32).
II.E. HOST CELL RANGE OF CORONAVIRUSES.
Most coronaviruses are highly species specific, causing disease only 
in the species from which the virus was isolated, and demonstrate a 
marked degree of tissue tropism. For example, IBV is restricted to 
diseases of the respiratory tract, the site of virus replication. TGEV 
and bovine, canine, and turkey coronavirus replicate in the intestinal 
epithelum, causing enteric infections. The human coronaviruses HCV-229E 
and HCV-OC43 cause respiratory infections, and the human enteric 
coronavirus (HECV) is a cause of infantile enteritis (5,76,100). 
Coronaviruses were isolated from the brains of patients with multiple 
sclerosis (15,109). Murine coronaviruses cause respiratory, enteric, 
and neurological diseases in mice (47). Two cases of cross species 
infection have been reported - a natural infection of dogs by TGEV, and 
an accidental transmission of BCV to man (72,113,127).
Typically, coronaviruses do not replicate well in cell culture, 
usually requiring organ cultures or differentiated cells from the host 
species (47). Some strains of BCV and HECV do not replicate in cultured 
cells and have been identified by electron microscopy of diarrhea fluids
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(5, 100, and Storz, personal communication). Mebus and coworkers (84) 
adapted BCV-L9 to culture using primary cultures of bovine fetal kidney 
cells. Successful culture systems using established cell lines have 
been developed for several coronaviruses. Avian and bovine 
coronaviruses replicate well in Vero cell lines (1,121). The 
adenocarcinoma cell line, HRT-18, established by Tompkins et al (122), 
is used for propagation of BCV (63,133). Enhancement of the replication 
of coronavirus in culture was accomplished by including trypsin in the 
culture medium (37,97,114,124,133,135).
Depending on the host cell, coronavirus infections may range from 
highly cytocidal to inapparent (47). In cytocidal infections cells may 
fuse into syncytia or lyse. In contrast, feline, murine, human, and 
avian coronaviruses are able to establish persistent infections leading 
to carrier cultures in some cell culture systems (47,48,23,75). The 
mechanism of resistance of cells to coronavirus infection is mostly 
unknown. Boyle et al (8) demonstrated that genetic resistance of the 
inbred mouse strain SJL/J to MHV infection is due to the lack of a 
receptor which is present on susceptible mice.
II.F. PROTEOLYTIC ACTIVATION OF THE ENVELOPE PROTEINS OF 
PARAMYXOVIRUSES AND ORTHOMYXOVIRUSES
Proteolytic activation of infectivity and cell fusion was first 
observed in paramyxoviruses. Hosaka in 1967 (134) and Young and Ash in 
1970 (136) reported a decrease in the cell-fusing activity of Sendai 
virus and Newcastle disease virus following a single passage in tissue 
culture. Classically, Homma (51,52) and Homma and Tamagawa (54) noted 
that Sendai virus propagated in chicken embryos was infectious and
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induced cell fusion in L cells, and was hemolytic to guinea pig 
erthrocytes. After a single round of replication in L cells, Sendai 
virus was noninfectious, did not induce fusion, and was nonhemolytic. 
Trypsin treatment of purified Sendai virus restored all three biological 
activities. Cell-fusing activity, hemolysis, and infectivity are a 
result of cleavage of an inactive precursor molecule, Fo, to its active 
subunits, FI and F2, by host cell proteases or by trypsin 
(51-54,93,99,106). Since its identification in paramyxoviruses, 
proteolytic activation of infectivity was identified in other viruses. 
Orthomyxoviruses, rotaviruses, and coronaviruses require cleavage of 
precursor proteins for activation of viral infectivity and/or cell 
fusing activity (35,37,39,97,114,124,133,135).
II.F.l. Paramyxoviruses.
Two surface glycoproteins are found on paramyxoviruses - 
hemagglutinin - neuraminidase (HN) and fusion (F). HN is a 72 Kd 
protein which is responsible for adsorption of the virus to host cell 
neuraminic acid receptors and cleavage of viral neuraminic acid residues 
to prevent self aggregation during release from the cell. The protein 
is a dimer of identical disulfide-linked molecules. Studies with 
Newcastle disease virus show that inactive HNo is cleaved to yield the 
active HN molecule. Failure to cleave the precursor molecule results in 
noninfectious virus (93).
The 65 Kd F protein allows penetration into the host cell by lysing 
the host cell membrane and causing fusion of the viral envelope and cell 
membrane. The nucleocapsid can then be released into the cell
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cytoplasm. The presence of F protein on the surface of infected cells 
also induces lysis of membranes and cell fusion (24).
An inactive precursor polypeptide, Fo, is initially produced in 
infected cells. Fo is cleaved by host cell protease to FI and F2 
subunits (52 Kd and 13 Kd, respectively). These subunits are disulfide 
linked to form the F protein. FI contains the carboxy terminus of the 
precursor molecule and is anchored in the viral envelope, and F2 
contains the original N terminus. Cleavage of Fo reveals a new N 
terminus on FI that is very hydrophobic and contains 18 highly conserved 
amino acids (25). The hydrophobic sequence is important in fusion of 
virus-cell membranes and infected cell-uninfected cell membranes.
II.F.l. Orthomyxoviruses
Orthomyxoviruses have two surface glycoproteins - hemagglutinin (HA) 
and neuraminidase (NA). HA functions in attachment of the virus to 
sialic acid-containing glycoproteins on the cell surface and in 
penetration into the cell during initial stages of infection. Outbreaks 
of influenza are attributed mainly to variation in HA protein. The 
function of NA is unclear, but its enzymatic activity may prevent 
aggregation of virus particles and promote release from infected cells 
by removing receptors from HA, itself, and the infected cell surface 
(92,98). The NA protein consists of a single polypeptide which 
undergoes no post-translational processing.
The HA protein is synthesized as a single polypeptide of 75 to 80 Kd 
(28). Following post-translational cleavage of the N terminal signal 
sequence and removal of one or more intervening amino acid residues, two 
polypeptides result. HA1 and HA2 (36 and 27 Kd, respectively) are
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linked by a single disulfide bond, and a trimer of these molecules 
comprises the HA spike (92).
Garten and coworkers (39) identified the amino acid sequence at the 
cleavage site of the HA protein. In the active form, the C terminus of 
HA1 has the sequence gln-ser, and the N terminus of HA2 has the sequence 
gly-leu-phe-gly-ala-ile. Activation of the protein is accompanied by an 
acidic shift in the isoelectric point of HA, indicating that an 
intervening arginine residue is removed from the cleavage site. Two 
proteases are involved in the activation of HA: trypsin or a 
trypsin-like endoprotease of cellular origin to cleave the arg-gly bond; 
and an exopeptidase of the carboxypeptidase B type to remove the 
arginine. In vitro cleavage of HA in the presence of purified virus and 
trypsin resulted in removal of the arginine residue. Therefore, this 
enzyme is either a host component tightly associated with the virus 
particle or a virus-encoded protein. Interestingly, cleavage by 
chymotrypsin or thermolysin only slightly shifts the cleavage site, but 
these do not activate HA. Consequently, activation of HA involves a 
highly specific cleavage site. Cleavage of the precursor molecule into 
HA1 and HA2 is required for viral infectivity. Orthomyxoviruses exhibit 
low infectivity if grown in cells lacking the proper proteases, but the 
virus can be activated by treatment with trypsin (92).
II.G. PROPERTIES OF NEWLY RECOGNIZED GASTROENTERITIS AGENTS: THE
TOROVIRUSES
The proposed family Toroviridae is composed of two recognized 
gastroenteritis agents - Berne virus (BEV) and Breda virus (BRV). Berne 
virus was isolated in 1972 from a rectal swab of a diarrheic horse in
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Berne, Switzerland (130). Breda virus was obtained during an acute 
epizootic of neonatal calf diarrhea in Breda, Iowa in 1982 (134). A 
morphologically similar and antigenically related virus was detected in 
cattle from Lyon, France and named Lyon 4 virus (89,90). Virus 
particles resembling BEV and BRV were isolated from humans with 
gastroenteritis (6,55).
Morphologically, toroviruses are pleomorphic particles measuring 
120-140 nm, and were described as spherical, oval, elongated, or 
kidney-shaped particles. These viruses are enveloped and surrounded by 
drumstick-shaped peplomers of 20 nm in length. The nucleocapsid is 
elongated, tubular, and probably helical. The name "Toroviridae" was 
derived from the Latin torus = a doughnut shaped ring. The RNA genome 
of these viruses is single-stranded with a molecular weight of 5.7 x 10^ 
d. The genome is polyadenylated and infectious and probably of positive 
polarity (130,134).
BEV and BRV are structurally similar, consisting of proteins in the 
molecular weight range 75-100, 37, 22, and 20 Kd. The 20 and 37 Kd 
proteins of BEV are phosphorylated, and the 20 Kd species is the most 
prevalent protein. This protein has RNA binding properties and 
represents the major capsid protein. The 22 Kd protein probably serves 
as a constituent of the envelope, while the phosphorylated 37 Kd species 
may be a matrix protein. The 75-100 Kd glycoproteins are tunicamycin 
sensitive, probably containing N-linked oligosaccharides (129).
Toroviruses are extremely UV sensitive, but withstand pH extremes of 
2.5 to 10.3. Infection of susceptible hosts is probably by ingestion 
(134). BRV was shown by immunofluorescence and electron microscopy to 
replicate in vivo in epithelial cells of the colon, the caudal part of
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the jejunum, and the ileum. Crypt cells and villous cells of the ileum 
and jejunum are infected, as are most cells of the large intestine 
(129,134). BEV replicates in cell culture in equine cells, but attempts 
to propagate the virus in other mammalian cells were unsuccessful (130). 
BRV and human toroviruses do not replicate in any culture system 
attempted so far (6).
The replication of BEV was inhibited by treatment of infected cells 
with actinomycin D,a -amanitin, and UV irradiation, indicating some 
nuclear involvement in the replication of BEV. Within 6 hours post 
infection virus-specific proteins were evident in BEV infected equine 
dermal cells. A glycosylated, tunicamycin-sensitive species of 200 Kd 
was detected which was shown to be a precursor of the 75-100 Kd protein. 
Six or seven subgenomic and 1 genome-sized RNA species were extracted 
from BEV-infected equine dermal cells. These RNAs were polyadenylated 
and served as messenger. Tubular structures representing nucleocapsid 
were detected in the cytoplasm and nucleus of infected cells.
Assembly of the virions involves budding of a preformed rigid 
nucleocapsid through intracytoplasraic membranes. Budding occurs 
predominantly through the Golgi and to a lesser extent through the rough 
endoplasmic reticulum. Nucleocapsid attaches to the membrane and buds 
through the membrane, apparently acquiring its diameter and electron 
density. Enveloped, rod-shaped virus is found in the lumen of the 
cytoplasmic cisternae. Virus is released after virus-containing 
vesicles merge with the plasma membrane. The morphology of the virus 
changes from rod-like to the torus form during transmission from the 
intravesicular to the extracellular state (129).
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The morphology, genetics, and replication of toroviruses closely 
resemble coronaviruses. Both viruses replicate in the intestinal 
epithelium, causing gastroenteritis. The identification of these 
disease agents has obvious implications from the standpoint of 
prevention or diagnosis of gastroenteritis infections. Further study of 
toroviruses on the molecular level is necessary to fully understand the 
replication of the viruses and their major differences from 
coronaviruses.
TABLE II.1 Numbers of Structural Proteins of Various Coronaviruses
Virus Source No. Proteins Reference
Mouse Hepatitis virus 17C11, Sac-, L2 cells 5-6 (101,119,128)
Diarrhea virus of infant mice DBT cells 4 (120)
Human coronavirus-229E mrc5 6 (62)
Human coronavirus-OC43 HRT-18 cells 4 (46)
Human enteric coronavirus 24 and 25 diarrheic fluid 9 (5)
Human enteric coronavirus 14 human fetal intestinal organs 5 (100)
Bovine enteropathogenic coronavirus diarrheic fluid, HRT-18 cells 7-10 (42,133)
BEK-1 cells, HRT-18 cells 5-6 (46,63,64,71,126)
Rabbit enteric coronavirus diarrheic fluid 8 (31)
Transmissible gastroenteritis virus primary pig kidney cells 4 (41)
Hemagglutinating encephalomyelitis 
virus
primary pig kidney cells 8 (17)
Canine coronavirus dog kidney cells 4 (40)
Feline coronavirus fetal cat whole fetus cells 4 (9)
Infectious bronchitis virus chorioallantoic membrane of 
de-embryonated chicken eggs
3 (18,19,20)
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TABLE II.2. Antigenic Groups of Coronaviruses Determined by 
Immunofluorescence Analysis
Group 1 Group 2
Avian Mammalian
Subgroup 1 Subgroup 2
Human Coronavirus-0C43 Human Coronavirus-229E
Bovine Coronavirus Transmissible Gastroenteritis
Mouse Hepatitis Virus Virus
Haramagglutinating encephalo- Feline Infectious Peritonitis 
myelitis Virus Virus
Rat Coronavirus Canine Coronavirus
Sialodacryoadenitis Virus 
Diarrhea Virus of Infant Mice 
Human Enteric Coronavirus
CHAPTER III. CHARACTERIZATION OF SPECIFIC PROPERTIES OF HRT-18 CELL
CLONES: CELL MORPHOLOGY, GROWTH PROPERTIES, PLATING
EFFICIENCIES, AND EXPRESSION OF BOVINE CORONAVIRUS 
III.A. INTRODUCTION
Human rectal tumor-18 (HRT-18) cells are used routinely for the 
propagation of bovine coronavirus (46,63,64,133). Turbid plaques 
containing some apparently normal cells were produced by BCV-L9 in 
HRT-18 cells. This observation indicated that the HRT-18 cell 
population is heterogeneous, consisting of subpopulations of cells which 
may differ in susceptibility to infection or in production of infectious 
virus. In hopes of isolating cell types that were either refractory or 
highly susceptible to BCV infection, HRT-18 cells were cloned by 
limiting dilution. All of the clones obtained by this method were found 
to be permissive to BCV, but there was some variation in the way virus 
infection was expressed cytopathically.
The HRT-18 cell line was established from an adenocarcinoma of the 
lower gastrointestinal tract. These cells are epithelial, with large 
nuclei and scanty cytoplasm. By ultrastructural examination, numerous 
uniform, frequently parallel microvilli are evident. The microvilli 
cover the apical surface of the cells, closely resembling the brush 
border of intestinal epithelium. Cytogenetic analysis of HRT-18 at the 
thirty-second passage showed a mode of 48 chromosomes, but additional 
chromosomes appeared randomly, mostly in karyotype groups D and E. 
Chromosome loss was not evident (122).
The purpose of this investigation was to analyze putative 
differences between four HRT-18 cell clones, 3F3, D2, 3E3, and 4B3. The 
clones were characterized according to cell morphology, growth
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properties, and plating efficiencies. Further, these cells were 
infected with BCV-L9 to assess the susceptibility of each clone to 
infection based on cytopathic expression of the virus.
III.B. MATERIALS AND METHODS
III.B.l. Cells and Media
HRT-18 clones 4B3, D2, 3E3, and 3F3 were isolated from HRT-18 cells 
at approximately the 30th passage level by limiting dilution, and stocks 
were prepared. All clones were at the 8th passage level for these 
experiments. HRT-18 parent cells were used at passage 55 for these 
investigations. Cells were grown in Dulbecco's Modified Minimum 
Essential Medium (DMEM) with 44 mM NaHCO^ buffer. Penicillin (100 
units/ml)-streptomycin (100 ug/ml) was added to the medium. Medium was 
supplemented with 5% fetal calf serum for routine cell maintenance, but 
no serum was used during virus propagation.
III.B.2. Screening for Contaminating Mycoplasma or Viruses
Culture supernatant was inoculated into Modified Hayflick broth (96) 
then streaked onto Modified Hayflick Agar containing 1000 IU/ml of 
Penicillin G to assay for contaminating Mycoplasma. Cells were also 
examined on the ultrastructural level for Mycoplasma or contaminating 
viruses using transmission and scanning electron microscopy.
III.B.3. Immunofluorescent Analysis of Plaques Formed by BCV-L9 in 
HRT-18 Cells
Confluent monolayers of HRT-18 cells in 6-well polystyrene plates 
were inoculated with 0.5 ml of 10-fold serially diluted BCV-L9. After a 
1 h adsorption period, excess inoculum was aspirated from the wells,
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cells were washed, and 3 ml of DMEM containing 0.6% agarose (Gibco, 
electrophoresis grade) was added to the wells. The plates were 
incubated at 37°C in 5% CC^. Cells were fixed at 48 h post infection 
with 4% paraformaldehyde for 15 min, and the overlays were removed.
Cells were rinsed with PBS, pH 7.4, then post-fixed with methanol for 5 
min., rinsed with PBS, and dried. Serum 1745 (a bovine serum for tissue 
culture) was diluted 1:20 in PBS, added to the wells, and incubated at 
37°C for 30 min. Cells were washed 3 times for 5 min. each with PBS and 
dried. Rabbit anti-bovine IgG (H and L chain) FITC-conjugated antiserum 
(U.S. Biochemical Corp.) was diluted 1:16 in PBS, added to wells, and 
incubated at 37°C for 30 min. Three 5 rain. PBS washes were done as 
before, and cells were dried. A 0.002% Evan's blue solution was used to 
counterstain the cells for 2 min., then the cells were briefly rinsed 
with PBS and dried. A drop of buffered glycerol mounting medium was 
used to mount coverslips, and coverslips were sealed with nail polish. 
Plaques were examined microscopically using a Zeiss epifluorescence 
microscope equipped with a 40 X oil immersion lens.
III.B.4. Virus
BCV strain L9 was adapted to cell cultures by Mebus et al (84) using 
bovine fetal kidney cells. The virus used in these investigations was 
passaged 42 times in bovine fetal kidney cells, 16 times in bovine fetal 
brain cells, 15 times in bovine fetal spleen cells, and 8 times in 
HRT-18 cells.
III.B.5. Infection of Cells
Monolayers of each HRT-18 clone in 25 cm2 tissue culture flasks were 
infected with BCV-L9 at a multiplicity of infection (MOl) of
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approximately 3 x 10 PFU/cell. Following an adsorption period of 1 h 
at 37°C, excess inoculum was removed, and DMEM was added to the cells. 
Infected flasks were incubated for three days, then cytopathic 
expression was monitored by phase-contrast microscopy and photographed.
III.B.6. Analyses of Cell Morphology
Confluent flasks of each clone were trypsinized and viable cell 
counts were made using the trypan blue exclusion method and a 
hemacytometer. 60 mm Petri plates were seeded with 1 x 10^ cells.
After 24, 48, and 72 h incubation, cells were fixed with Bouin's 
solution and stained with Giemsa. Confluent monolayers (4 days after 
passage) of each clone were examined by phase-contrast microscopy and 
photographed.
III.B.7. Evaluation of Growth Properties
Following viable cell counts (described above) cells were seeded
2 5into 25 cm flasks at a density of 2 x 10 cells/ml in 5 ml medium.
Flasks were incubated at 37°C. At 24 h intervals duplicate flasks of
each cell type were trypsinized and viable cell counts were made. The
average cell count at each time period was calculated, and growth curves
were drawn by plotting viable cells versus time (h). From the growth
curves the doubling time, generation time, population density, and
saturation density for each clone was extrapolated. Doubling time was
the number of hours required for viable cell count to reach 2 x 10^
cells. Generation time was obtained by averaging 3 doubling times taken
from the logarithmic phase of growth. The saturation density (maximum
number of viable cells obtained) was the value where three successive
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cell counts showed no increase in number. The population density was
2the saturation density/cm .
III.B.8 Evaluation of Plating Efficiency
Triplicate 60 mm Petri plates were seeded with 100, 500, 1000, or
10,000 viable cells in 5 ml medium. Plates were incubated at 37°C in 5%
CO^ . After a 6 day incubation period, cells were fixed with Bouin's
solution and stained with Giemsa. Colonies consisting of 4 or more
cells were counted, and the plating efficiency was calculated as follows
(38): No. colonies formed x 100
No. cells seeded
The plating efficiency reported was the average of the three plates 
counted.
III.B.9. Plating Efficiency in Soft Agar
The efficiency of colony formation in soft agar was assessed 
according to a modification of the method used by MacPherson and 
Montagnier (79). Base layers of 7 ml medium containing 0.5% agarose in 
60 mm Petri dishes were allowed to solidify. A second layer seeded with 
100, 500, 1000, or 10,000 cells in 1.5 ml medium plus 0.3% agarose was 
added. Plates were prepared in triplicate for each clone and incubated 
at 37°C in 5% CO2 . Cell counts were done after 9- and 21-day 
incubations, as follows: Plates were sectioned into quarters. All
cells within microscopic fields at a fold magnification of 200 X were 
counted until a total of 25 cells per quarter had been counted. The 
number of colonies within this population which contained 4 or more 
cells was determined. The efficiency of colony formation was the 
average of the triplicate counts.
III.B.10. Statistical Methodology
The Statistical Analysis System (105) was used to analyze the data 
with the general linear models (GLM) procedure and Tukey's Studentized 
Range Test for analysis of individual mean differences. All individual 
mean separation tests were considered significant at a probability level 
of 0.05.
III.C. RESULTS
III.C.l. Screening for Contaminants
No contaminating Mycoplasma or viruses were evident in culture or by 
ultrastructural examination.
III.C.2. Immunofluorescent Analysis of Plaques Formed by BCV-L9 in 
HRT-18 Cells
Microscopic evaluation of the fluorescent antibody-stained plaques 
revealed fluorescing cells within the center of the plaques, indicating 
the presence of BCV-L9 antigen. Among the fluorescing cells within the 
plaque center were many cells which did not express viral antigens (Fig.
III.l).
III.C.3. Analyses of the Morphology of HRT-18 Clones
HRT-18 clones, like the parent cells, were polygonal in shape. The 
nuclei were large and ovoid to pleomorphic and surrounded by a meager 
cytoplasm. Some differences in developmental morphology were seen in 
Giemsa-stained cultures. After 24 h growth, only a few single cells 
were present in clone 3F3 cultures. Well-defined, tightly-packed 
colonies of different sizes had developed (Fig. III.2.A). Giemsa- 
stained cultures of clone D2 consisted of a large number of single
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cells. Colonies formed by this clone were poorly defined and loosely 
associated (Fig. III.2.B). Clone 3E3 produced small, discrete colonies 
of similar size within 24 h (Fig. III.2.C). Some large, densely-packed 
colonies were formed by 4B3 cells, but most colonies consisted of only a 
few cells (Fig. I1I.2.D). Within 72 h, clones 3F3, 3E3, 4B3 had 
coalesced into confluent monolayers but, growth was slower for clone D2.
Although difficult to demonstrate in a single micrograph, each clone 
exhibited characteristic patterns within the monolayer that were evident 
by phase-contrast microscopy. The patterns included a distinct surface 
topography and orientation of cells that was consistent and reproducible 
with subpassage. Vacuolation of cells occurred for each clone, but it 
consistently appeared earliest in clone D2, and to lesser extents in the 
other three clones (Fig. III.3.A-D).
III.C.4. Assessment of Growth Properties of HRT-18 Clones
The growth curve of each cell type showed the classical lag, 
logarithmic, stationary, and death phases of growth (Fig. III.4). The 
growth properties demonstrated by each clone are summarized in Table
III.l. Each cell type exhibited a different doubling time. The 
shortest doubling time of 27 h was found for clone D2, while clone 4B3 
required 52 h to double its cell population. Clone 4B3 was the only 
cell type to exhibit an initial decrease in viable cell count at the 24 
h incubation period. This drop in viable cells also occurred with the 
HRT-18 parent cells, which had a 52 h doubling time. The generation 
times for clones 3F3, 4B3, D2, and parent cells were similar at 21, 21, 
18, and 20 h, respectively, but it was 30 h for clone 3E3. The kinetics
39
of growth for clone 4B3 most closely resembled those of the HRT-18 
parent cells.
Saturation densities for clones 3E3, 4B3, and D2 were approximately
8 million, while the saturation density was less than 7 million for
5 2clone 3F3. Population densities of approximately 3 x 10 cells/cm were 
obtained. The maximum viable cell count for HRT-18 parent cells was 4 
to 5 million cells higher than those of the clones, but these cells were 
assayed in a separate experiment. Therefore, the higher counts may be 
attributable to slightly different culture conditions.
III.C.5. Plating Efficiency
The plating efficiencies were determined by counting the number of 
colonies of 4 or more cells per number of cells seeded. The set seeded 
with 100 cells was within the countable range, while the other three 
sets were too numerous to count. The plating efficiencies obtained for 
each clone are reported in Table III.2. Clones 3F3 and D2 plated with 
efficiencies of 100% and 77%, respectively. These values were 
significantly higher (F = 30.76, p<0.0002) than those obtained for 
clones 3E3 and 4B3 which had efficiencies of 33% and 50%, respectively.
Three basic colony types were apparent after Giemsa-staining: small
colonies consisting of only a few cells; intermediate colonies of about 
0.5 mm diameter; and large colonies of approximately 1 mm in diameter. 
The colony types produced by the clones are given in Figures III.5.A-D. 
All three types of colonies were produced by clone D2. Clones 3F3 and 
3E3 formed small and intermediate-sized colonies. Mostly large colonies 
were produced by clone 4B3.
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III.C.6. Growth in Soft Agar as an Indicator of Transformation
Table III.2. presents the efficiencies of colony formation in soft 
agar for each clone. The efficiencies of clones 3E3 and 4B3 were 
identical at 17%, and slightly lower at 15% for clone D2. The highest 
efficiency of 23% was produced by clone 3F3. Statistical analysis did 
not reveal significant differences between the clones.
III.C.7. Cytopathic Expression of BCV-L9 in each Clone.
All four HRT-18 clones were susceptible to BCV infection, but the 
cytopathic expression produced in each clone varied (Table III.3).
Clone 3F3 appeared to be the most susceptible to BCV infection because 
it produced the most extensive CPE (Fig. III.6.A). The monolayer was 
heavily vacuolated, and areas of fused cells were observed. The 
cytopathic changes of infected clones D2 and 3E3 were less extensive 
than 3F3. Although milder, cytopathic expression also included 
vacuolated monolayers and areas of cell fusion (Figs. III.6.B and C). 
Based on cytopathic expression, clone 4B3 appeared the least affected by 
infection (Fig. III.6.D). Some vacuoles developed in the monolayer of 
this infected clone, and some cells rounded up and detached. Cell 
fusion was not seen in clone 4B3.
Ill.D. DISCUSSION
Turbid plaques are produced by BCV-L9 in HRT-18 cells.
Immunofluorescent analysis of these plaques revealed that many of the 
cells within the plaques did not express viral antigen. Presumably, the 
non-fluorescing cells represent cells which are non-permissive to virus 
infection or incapable of replicating internalized virus. HRT-18 cell
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clones were established in an attempt to isolate both refractory and 
susceptible cell types.
HRT-18 clones 3F3, D2, 3E3, and 4B3 were characterized to assess 
putative differences between the cell lines. The four clones exhibited 
differences in morphology both in Giemsa-stained cultures and in 4--day 
monolayers. The basis for these differences is unknown. The diversity 
in colony size and number of single cells observed after 24 h incubation 
probably reflects each clone's ability to readjust to culture following 
trypsinization or differences in rate of growth. Variation in the 
cultural morphology may indicate differences in cell size, the 
orientation of junctional complexes (desmosomes) between cells, and/or 
varied degrees of contact inhibition. These traits contribute to the 
proximity between cells and the way the cells pile up in culture. In 
combination, these characteristics could contribute to the unique 
cultural patterns displayed by each clone. Vacuolization of the cells 
was a morphological characteristic which probably reflects the aging 
process.
Studies of the growth properties of the cells were conducted to 
assess any variance between the clones in kinetics of growth. Each 
clone required a unique period of time to double in number, indicating 
that the log or adjustment phases were dissimilar. All clones except 
3E3 showed a similar generation time. Therefore, 3 of 4 clones 
multiplied logarithmically at approximately equal rates, with clone 3E3 
multiplying at a somewhat slower rate. Similar saturation densities 
were obtained by clones D2, 4B3, and 3E3, indicating that the growth 
rates leveled off and allowed nearly the same cell numbers to be 
achieved. The maximum cell count was over 1 million cells fewer for
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clone 3F3. The viable cell counts were reduced to a different level for 
each clone at the final count of 260 h. For example, the count did not 
deviate from the saturation density for clone 3F3, but decreased by 4 x 
10^ cells for clone 3E3.
The growth of the HRT-18 parent cells was assayed at a different 
time than the clones, and the higher saturation density may have 
resulted from slightly different culture conditions. Clone 3F3 formed 
colonies to the highest efficiency both under normal culture conditions 
and in soft agar. MacPherson and Montagnier (79) found that BHK- 21/13 
cells, transformed by polyoma virus, formed colonies in soft agar medium 
while uninfected cells did not. This procedure demonstrates anchorage 
independence and is an indicator of transformation. All the clones 
shared this transformed quality, but it was most apparent in clone 3F3. 
It is likely that the extent of transformation is greatest in this 
clone. Perhaps transformed traits such as cell membrane changes or 
increased metabolic activity contribute to the extreme susceptibility of 
clone 3F3 to BCV infection.
According to a study of HRT-18 cells at passage 6-12 done by 
Tompkins et al (122), the generation time for the cells was 31.1 h and 
the plating efficiency was 91.3%. These data most closely resemble 
those obtained for clone 3F3. This study demonstrated that HRT-18 at 
passage 55 had a doubling time and generation time nearly identical to 
clone 4B3. Perhaps the growth properties of the HRT-18 cells shifted 
from predominately 3F3-like characteristics at low passage to 
predominately 4B3-like characteristics at high passage.
All four clones were susceptible to BCV infection, but the 
cytopathic expression produced as a result of BCV infection differed
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between the clones. Several plausible reasons may explain this result: 
a) The clones may process the virus differently. Cellular proteases may 
be produced at different levels or not at all in some cells, allowing 
the virus to replicate more efficiently in a particular clone. 
Presumably, cell fusion is a consequence of proteolytic cleavage and 
activation of the cell-fusing ability of this virus. Frana and 
coworkers (37) demonstrated varied ability to induce cell fusion when 
four different murine cell lines were infected with MHV. These cell 
lines processed the 180 Kd glycoprotein differently, b) The cell 
membrane plays a major role in cell fusion. Huang (57) showed that 
glycolipids are involved in membrane fusion. Glycolipids containing 
galactose at terminal positions inhibited hemolysis and fusion of 
erythrocytes by Sendai and influenza viruses. The investigator assumed 
that the lipids interfered with the fusion process by competing with 
viral glycoproteins responsible for fusion. In studies of liposome 
fusion by Sendai virus, the presence of gangliosides in the liposomes 
was essential for fusion (44,45). Miyake and other investigators (88) 
demonstrated the involvement of the cytoskeleton in cell fusion by 
disrupting microfilaments with cytochalasin D and inhibiting fusion. 
Therefore, it is quite possible that the appearance of cell fusion in 
clones 3F3, D2, and 3E3 but not 4B3 may reflect differences in the 
composition of the cell membranes, c) The HRT-18 clones possibly have 
different receptor proteins on their surfaces, or the virus receptor may 
appear more frequently on certain clones. This would contribute to 
different levels of infection. The lack of a virus receptor on the 
target tissues of mice genetically resistant to MHV was demonstrated 
(8). d) Perhaps the replication and/or morphogenesis of the virus
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occurs with varied efficiency in the clones. Lytic infections with MHV 
showed coordinated synthesis of viral proteins throughout infection, 
while in non-cytocidal infections, synthesis of the N protein appeared 
earlier. Pulse-chase experiments demonstrated different rates of 
shut-down of host protein synthesis for MHV-infected cells (117). Any 
one of these phenomena or a combination of them may explain the 
differences that the clones exhibit in expression of virus infection.
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Table III.l. Growth Properties of HRT-18 Cells
Doubling Generation Saturation Population
Clone Time (h) Time (h) Density (cells) Density (cells/cm )
3F3
3E3
4B3
D2
HRT-18
parent
30
36
52
27
52
21
30
21
18
20
6.7 x 10
8.1 x 10
7.6 x 10
8.3 x 10
11.9 x 10
2.7 x 10"
3.2 x 10"
3.0 x 10"
3.3 x 10'
4.8 x 10'
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Table III.2. Efficiencies of Colony Formation for HRT-18 Cell Clones
Efficiency of Colony Formation 
Clone Plating Efficiency in Soft Agar
3F3
3E3
4B3
D2
100%
33%
50%
77%
23%
17%
17%
15%
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Table III.3. Cytopathic Expression of BCV-L9 in HRT-18 Cell Clones
Clone Extent of
Cytopathic
Expression
Cytopathic Expression
4B3
D2
3E3
3F3
Minimal
Moderate
Moderate
Extensive
Vacuoles 
Cell rounding 
Vacuoles 
Cell fusion 
Vacuoles 
Cell fusion 
Vacuoles 
Cell fusion
\
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Figure III. 1. Photomicrograph of a Plaque Produced by BCV-L9 
in HRT-18 Cells and Examined by
Immunofluorescent Analysis. Magnification - 400 X
/Figure III. 2. Photomicrograph of Giemsa-Stained, 24 h Cultures 
of HRT-18 Clones. A. Clone 3F3 B. Clone D2 
C. Clone 3E3 D. Clone 4B3 Magnification - 
100 X
Figure III. 3. Phase-Contrast Photomicrograph of Confluent 
Monolayers of HRT-18 Clones. A. Clone 3F3 
Clone D2 C. Clone 3E3 D. Clone 4B3 
Magnification - 200 X
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Figure III. 4. Growth Curves of HRT-18 Clones and Parent Cells.
\
Photomicrograph of Colonies Produced by HRT-18 
Clones. Giemsa-Stained Cultures. A. Clone 3F3 
B. Clone D2 C. Clone 3E3 D. Clone 4B3. 
Magnification - 100 X
Figure III. 6. Phase-Contrast Photomicrograph of 
BCV-L9-Infected HRT-18 Clones. A. 
B. Clone D2 C. Clone 3E3 D. 
Arrows indicate fused cells. 
Magnification - A,B - 200 X
Clone 3F3 
Clone 4B3.
CHAPTER IV. INFLUENCE OF HOST CELL, VIRUS STRAIN, AND TRYPSIN
MODIFICATION ON BCV CYTOPATHIC EXPRESSION AND PLAQUE 
FORMATION.
IV.A. INTRODUCTION
An infectious form of Sendai virus was produced in chicken embryos. 
The virus was hemolytic and activated cell fusion. Propagation of 
chicken embryo-borne Sendai virus in L cells resulted in a single round 
of replication, and the L cell-borne Sendai virus was noninfectious, 
nonhemolytic, and did not induce fusion. Treatment of the L cell-borne 
virus with trypsin activated the three biological activities.
Activation of the virus was a result of cleavage of the inactive 
precursor protein Fo to the subunits Fl and F2 which are disulfide 
linked to form the active F protein (51-54,93,99,106). Proteolytic 
activation of viral infectivity was also reported for Newcastle disease 
virus and orthomyxoviruses (24,39,99).
Coronaviruses appear to have a dependence on the host cell for 
replication in culture. The spectrum of cytopathic expression ranges 
from mild to highly cytocidal according to the virus strain and the host 
cell. Cytocidal infections may cause cell fusion and polykaryon 
development or cell lysis. In contrast, persistent coronavirus 
infections were reported in some cell lines (23,48,75). Many strains of 
coronavirus do not replicate in culture. Frana and coworkers (37) 
reported host-dependent processing of the structural proteins of 
MHV-A59. They found that activation of the viral fusion factor was due 
in part to cleavage of the 180 Kd peplomer to 90 Kd subunits. Trypsin 
enhanced the cell-fusing activity of this virus (37,119,135). A 
trypsin-dependent increase in cell-fusing activity and plaque
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development of bovine coronavirus was demonstrated using bovine fetal 
brain and bovine fetal thyroid cells (114).
The purpose of this study was to determine the effect of the host 
cell, virus strain, and trypsin modification on the cytopathic 
expression and plaque development of bovine coronaviruses. For this 
investigation cells which varied in susceptibility to infection were 
used, and several wild-type virus isolates, as well as strain L9 were 
assayed.
IV.B MATERIALS AND METHODS
IV.B.l. Cells
HRT-18 parent cells and HRT-18 cell clones 3F3, D2, 3E3, and 4B3 
were maintained as described in Chapter III. D2BFS cells were derived 
from bovine fetal spleen cells. They are a population of cells which 
survived precrisis and continue to multiply well past the thirtieth 
passage. D2BFS cells were maintained in Eagle's Minimum Essential 
Medium (MEM) containing 25 mM Hepes and penicillin (100
units/ral)-streptomycin (100 ug/ml). MEM was supplemented with 10% fetal 
calf serum. No serum was used in the presence of virus.
IV.B.2. Virus
BCV-L9 and 5 wild-type strains (isolated from Colorado and Utah) 
were used. Wild-type isolates were designated Meeker, Miller, Fisher, 
Calf 50, and LY-138. These isolates were obtained from diarrhea fluids 
of sick calves and were passaged 2-3 times in HRT-18 cells.
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IV.B.3. Propagation of Virus in Different Cells
2Monolayers of HItT-18, clones, and D2BFS cells in 25 cm flasks were
infected in duplicate with BCV. BCV-L9 was inoculated at an MOI of 3 x 
-310 PFU/cell. Stock wild-type strains were inoculated at approximate 
MOIs of 1 and 0.1 PFU/cell. Cells were infected as described in Chapter
III. Following a 1 h adsorption period, excess inoculum was removed, 
and 5 ml of medium was added. One flask from each set received 
trypsin-free medium, the other set received medium + the maximum 
concentration of trypsin which did not produce damage to the cell 
monolayers. 5 ug/ml trypsin was used with HRT-18 cells; 7.5 ug/ml 
trypsin (Difco 1:250) was used with D2BFS. All flasks were incubated at 
37°C and monitored daily for CPE.
IV.B.4. Plaque Formation
Confluent monolayers of HRT-18 cell clones 3F3, D2, 3E3, and 4B3 in 
6-well polystyrene plates were infected with 10-fold serially diluted 
virus (0.5 ml/well in paired wells). The overlay medium consisted of 
DMEM + 0.6% agarose (Gibco, electrophoresis grade). Trypsin (Difco, 
1:250, 2.0 ug/ml) was added to the overlay of half the wells. After a 
3-4 day incubation period, cells were stained for 2 h with neutral red, 
fixed with formalin saline for 10 min., and the overlays were removed.
IV.C. RESULTS
IV.C.l. Cytopathic Expression of BCV in Different Cells
The cytopathic expression of five wild-type BCV strains and strain 
L9 were analyzed in the presence and absence of trypsin using HRT-18 
parent cells, four HRT-18 cell clones, and D2BFS cells. The results of 
this investigation are given in Table IV.1. HRT-18 cells were
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permissive to all strains of virus. These cells were initially used for 
isolation of wild-type strains from diarrhea fluids and adaptation of 
the viruses to culture. Each strain of virus induced cell fusion in 
HRT-18 cells, and trypsin enhanced the cytopathic expression. Extensive 
fusion occurred in HRT-18 cells infected with strains L9 and Meeker in 
the presence of trypsin, while moderate fusion was a result of infection 
with strains Miller, Fisher, Calf 50, and LY-138. The cytopathic 
expression resulting from infection of HRT-18 cells with BCV-L9 with and 
without trypsin is demonstrated in Figure IV.1. D2BFS cells were 
non-permissive to infection by all the field isolates even in the 
presence of trypsin. Strain L9 replicated in D2BFS cells, but cell 
fusion only occurred in the presence of trypsin (Fig. IV.2). Strain L9 
replicated with varied intensity in the four HRT-18 cell clones.
Trypsin increased the cytopathic expression in clones 3F3, D2, and 3E3, 
but not in clone 4B3. Cell fusion was observed in all clones except 
clone 4B3.
IV.C.2 Plaque Development
The production of plaques by BCV-L9 was monitored in HRT-18 clones 
3F3, 3E3, D2, and 4B3 both with and without trypsin to assess any 
host-dependent differences in plaque formation (Fig. IV.3). The virus 
produced sharp, distinct plaques of 1-2 mm diameter in clone 3F3 within 
4 days post infection, and the plaques developed within 2-3 days in the 
presence of trypsin. The plaque diameter more than tripled, the plaques 
were less turbid, and they were more sharply defined when trypsin was 
included in the overlay. At least 4 different plaque phenotypes of L9 
were apparent. Small, turbid plaques of approximately 1-2 mm diameter
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developed in clone 4B3. The plaques were more distinct in the presence 
of trypsin but the plaques remained turbid, and the diameter was 
unchanged. Distinct plaques of about 0.5-2 mm diameter were formed by 
L9 in clone D2. Trypsin did not increase the size of these plaques, but 
the plaques were slightly less turbid and easier to see. Plaques were 
not evident in the 3E3 cell monolayer in the absence of trypsin.
Plaques remained indistinct, but they were apparent in wells containing 
trypsin.
Based on cytopathic changes, HRT-18 clones 3F3 and 4B3 represent 
highly susceptible and minimally susceptible cells to BCV infection, 
respectively. Consequently, the two clones were used to assess plaque 
formation by four wild-type strains of BCV. Plaques were not produced 
by any of the isolates in clone 4B3 either in the presence or absence of 
trypsin. In clone 3F3, plaques developed readily, and they were 
enhanced by trypsin (Fig. IV.4). Plaques ranging in size from 2-4 mm 
were produced by strain Miller. The number of detectable plaques 
increased with trypsin, but the plaques remained relatively turbid and 
of similar size to those produced without trypsin. The plaques formed 
by strain Meeker were 1 mm or 2 mm in diameter with fairly clear 
centers. These plaques were greatly enhanced by trypsin. Plaque 
diameters at least doubled, and the centers were very clear. Strain 
Calf 50 produced turbid plaques of 1-2 mm diameter in the absepce of 
trypsin. Plaques that developed with trypsin in the overlay were less 
turbid, but the size of the plaques did not increase significantly.
LY-138 formed mostly medium-sized, turbid plaques of about 2 mm diameter 
in the absence of trypsin. Some of the plaques were enhanced by 
trypsin, but other plaques within the monolayer exhibited no enhancement.
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IV.D. DISCUSSION
Host-dependent differences in the cytopathic expression of bovine 
coronaviruses were demonstrated in this study. HRT-18 parent cells 
allowed the replication of all strains of BCV. The four HRT-18 clones 
were permissive to infection with strain L9, and the cytopathic changes 
were different in these cells. In contrast, D2BFS cells only allowed 
the replication of the cell-adapted virus strain, L9, while these cells 
were non-permissive to infection by the wild-type strains.
Cell fusion was induced by all strains of virus in HRT-18 parent 
cells, and strain L9 induced fusion in clones 3F3, 3E3, and D2. Trypsin 
enhanced the CPE and cell fusion in these cells. Fusion was not evident 
in L9-infected clone 4B3 either with or without trypsin. These cells 
may be incapable of fusion due to the composition of the cell membrane 
(44,45,57,88), or they may process the virus differently. Cell fusion 
occurred in L9-infected D2BFS cells only in the presence of trypsin.
This finding indicates that these cells may lack a specific protease 
necessary for activating the cell-fusing activity of the virus. This 
situation is analogous to that found for Sendai virus propagated in L 
cells, which was reported by Homma and others (51,52,54).
Plaque formation was dependent upon the host cell line, the strain 
of virus, and the presence of trypsin in the overlay. Strain L9 
produced plaques in the four HRT-18 cell clones, but the ease of plaque 
production and the morphology of the plaques varied between the cells. 
Differences in the rate of replication of the virus in the clones could 
produce this result. Within a given incubation period, larger plaques 
would form in cells which allow rapid replication of the virus, while 
smaller plaques would develop in cells in which the virus replicates
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slowly. Trypsin dramatically enhanced the morphology of plaques 
produced in clone 3F3, but the morphology of the plaques formed in 
clones D2, 3E3, and 4B3 were less affected by trypsin. Enhanced plaque 
production of BCV-L9 by trypsin was also demonstrated in bovine fetal 
brain and thyroid cells (114).
Clone 4B3 was nonpemissive to plaque production by the wild-type 
BCV strains, but plaques developed readily in clone 3F3, again 
demonstrating the host-dependence of BCV replication. Each wild-type 
strain produced a number of distinct plaque phenotypes that were 
enhanced by trypsin. Since these virus stocks were not plaque purified, 
they probably consist of a variety of genotypically distinct viruses.
BCV-L9 is a highly cell-adapted strain of virus which replicates 
easily in culture. In contrast, the wild-type strains were isolated 
from diarrhea fluids and were passaged only 2-3 times in cultures of 
HRT-18 cells. The wild-type strains differ in cytopathogenicity in 
culture. Williams (132) reported differences in the polypeptide 
profiles of these viruses. Structural differences may affect the 
viruses' ability to adsorb to or replicate in a cell type, or affect the 
ease and extent of processing of viral proteins by the host cell or by 
trypsin. These factors probably contribute to the differences in 
cytopathic expression and plaque development observed in this study.
Table IV.1. Cytopathic Expression of BCV Strains in Different Cell 
Types.
Cells Trypsin L9 Miller Meeker Fisher Calf 50 LY-138
D2BFS A + - - - - -
P ++(ef) - - - - -
HRT-18
parent
A + (lf) + (lf) + (lf) + (lf) + (lf) +
P ++(ef) ++(mf) ++(ef) ++(mf) ++(mf) ++(mf)
Clone
4B3
A
P
+
+
ND ND ND ND ND
Clone
D2
A
P
+ (lf) 
++(mf)
ND ND ND ND ND
Clone
3E3
A
P
+ (lf) 
++(mf)
ND ND ND ND ND
Clone
3F3
A
P
+ (mf) 
++(ef)
ND ND ND ND ND
(If) - light fusion
(mf) - moderate fusion 
(ef) - extensive fusion 
A - trypsin absent 
P - trypsin present 
ND - not done
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Figure IV. 1. Phase-Contrast Photomicrograph of
BCV-L9-Infected HRT-18 Cells. A. (-) trypsin 
B. (+) trypsin 
Magnification - 100 X
Photomicrograph of BCV-L9-Infected D2BFS Cells 
Giemsa-Stained Cultures.
A. (-) trypsin B. (+) trypsin 
Magnification - 400 X
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Figure IV. 3. Plaque Development of BCV-L9 in HRT-18 Clones 
3F3, 4B3, D2, and 3E3. a - trypsin absent, 
p - trypsin present.
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Meeker
LY138
Figure IV. 4. Plaque Development of Wild-Type BCV Strains in 
Clone 3F3. a - trypsin absent, p - trypsin 
present.
CHAPTER V. THE INFLUENCE OF THE HOST CELL AND TRYPSIN TREATMENT ON BCV
INFECTIVITY.
V. A. INTRODUCTION
Proteolytic cleavage of surface proteins is a prerequisite for 
infectivity in a number of virus systems. Specifically, orthomyxovirus 
requires cleavage of the 75-80 Kd HA protein into the 36 Kd HA1 and and 
the 27 Kd HA2 species for the virus to be infectious. Activation of the 
cell-fusing potential and infectivity of paramyxovirus is a result of 
cleavage of the Fo precursor protein into FI and F2 (52 and 13 Kd, 
respectively) which are disulfide-linked subunits of the active F 
protein. Activation of the infectious potential of these two viruses is 
accomplished either by cellular proteases or by trypsin 
(25,39,51-54,92,99,106). The infectivity of rotaviruses can be 
increased if the outer capsid polypeptide VP3 is cleaved into VP5 and 
VP8 (60 Kd and 28 Kd, respectively). Cleavage by trypsin, elastase, or 
pancreatin causes an increase in infectivity of rotaviruses (35,74).
Proteolytic cleavage of the 180 Kd envelope protein of MHV into its 
90 Kd subunits activates the cell-fusing activity of this virus, but 
this cleavage pattern has not been correlated to an increase in the 
infectivity of the virus. Cell-dependent differences in processing of 
MHV proteins have been demonstrated (37,119). Trypsin enhances the 
plaque development and the cell-fusing capacity of murine, bovine, and 
avian coronaviruses (97,114,135). The polypeptide profile of BCV is 
altered by trypsin treatment (133). Toth (124) found that the rate of 
replication and the infectivity of BCV was enhanced when the virus was 
propagated in bovine embryonic lung cells in the presence of trypsin.
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In the previous chapter the effect of the host cell, virus strain, 
and trypsin modulation on the cytopathic expression and plaque 
development of bovine coronaviruses was examined. All three of these 
parameters affected the growth potential of BCV. The intent of this 
experimentation was to determine the influence of the host cell and 
trypsin treatment on the infectivity of the virus.
V.B. MATERIALS AND METHODS
V.B.l. Cells and Virus
HRT-18 parent cells, HRT-18 clones 3F3, D2, 3E3, and 4B3, and D2BFS 
cells were maintained as described in previous chapters. BCV strains L9 
and LY-138 were used in these assays.
V.B.2. Propagation of Virus in the Presence and Absence of Trypsin
2Cells were cultured in 25 cm tissue culture flasks until confluent.
Cells were washed with Dulbecco's PBS and infected in duplicate with BCV
— 9  —
strain L9 or LY-138 diluted 10 - 10 Using L9 the approximate MOI
was 3 x 10“3 - 3 x 10~7 PFU/cell for HRT-18 and 3 x 10_2 - 3 x 10~6
_2 — A
PFU/cell for D2BFS. The approximate MOI was 1.4 x 10 to 1.4 x 10
PFU/cell for LY-138 in HRT-18 cells. Virus was allowed to adsorb for 1
h at 37°C. For each cell type, paired flasks received either medium or 
the same medium containing trypsin. HRT-18 parent cells and clones 
received 5 ug/ml trypsin; D2BFS cells received 7.5 ug/ml trypsin. All 
flasks were incubated at 37°C for 48 h with CPE monitored daily. Flasks 
were frozen at -70°C, thawed, sonicated for 15 sec, and aliquots were 
frozen. Samples were titrated for virus yields by hemagglutination 
assay and plaque assay.
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V.B.3. Hemagglutination Assays
1% mouse erythrocytes were used for detection of BCV hemagglutinin. 
Two-fold serial dilutions of 25 ul virus samples were made in 96-well 
microtiter plates using PBS as diluent. Mouse red blood cells were 
added, and plates were agitated to assure mixing in wells. Plates were 
incubated at room temperature for 2 h or overnight at 4°C, then examined 
for agglutination of red blood cells.
V.B.4. Plaque Assays
Plaque assays were used to enumerate infectious virus. The assays
were performed as described in the preceding chapter using a 0.5 ml
inoculum.
V.B.5. Assessment of Infectious Units in the Virus Population
PFU:HA ratios were calculated from the titers obtained from plaque
assays and hemagglutination assays. A 0.5 ml inoculum was used in
plaque assays, and a 25 ul sample was tested by hemagglutination assay. 
These values represent the amount of infectious virus per 
hemagglutinating unit. Graphs were plotted as PFU:HA versus
inoculum virus dilution.
V.B.6. Propagation of BCV-L9 Using Different Trypsin-Treatment Schemes
2
Duplicate 25 cm flasks of confluent D2BFS cells were treated as 
follows:
Set 1) Cells were washed three times with Dulbecco's PBS, then treated 
with 2 ml of MEM containing 1 ug/ml trypsin (Sigma, TPCK treated).
Cells were incubated for 10 min at 37°C. Cells were washed to remove 
trypsin, then infected with L9 propagated in D2BFS cells without trypsin
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(MOI = 6 x 10 ^ PFU/cell). After adsorption for 1 h at 37°C, excess 
inoculum was removed, and cells were washed. MEM without trypsin was 
added to the flasks.
Set 2 - Cells were washed and infected with virus as described above.
After adsorption, MEM containing 1 ug/ml trypsin was added to flasks.
Set 3 - Virus was treated with 1 ug/ml trypsin for 30 min. at 37°C.
Trypsin activity was stopped by adding 1 ug/ml soybean trypsin inhibitor
(Sigma) and incubating for 30 min. at 4°C. Virus was diluted to an MOI 
-4of 6 x 10 PFU/cell and used to infect cells. After adsorption, medium
lacking trypsin was added to the flasks.
Set 4 - The virus was treated with trypsin as described above, then 
immediately diluted and used as inoculum. MEM containing 1 ug/ml 
trypsin was added after adsorption.
Set 5 - Cells were washed and infected with virus as described above. 
After adsorption MEM without trypsin was added.
All flasks were incubated for 24 h, then frozen at -70°C. Cells 
were thawed, sonicated, and aliquots were frozen. Yields were titrated 
from duplicate samples obtained from replicate flasks by plaque assay in 
HRT-18 cells. The four values were averaged to obtain the PFU titer.
V.B.7. Statistical Methodology
The Statistical Analysis System (SAS) (105) was used to analyze the 
data with the general linear model (GLM) procedure and Tukey's 
Studentized Range Test for analysis of individual mean differences. All 
individual mean separation tests were considered significant at a 
probability level of 0.05.
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V.C. RESULTS
V.C.l. Effect of Trypsin on BCV Infectivity
Infectivity ratios are displayed graphically as log^Q PFU:HA versus
inoculum virus dilution. An increase in PFU:HA occurred at dilutions 
-4 -510 and 10 when BCV-L9 was propagated m  D2BFS cells. At these 
dilutions there was no detectable infectious virus in the absence of 
trypsin, but a PFU:HA of greater than 5 log units occurred with trypsin. 
Enhanced infectivity was not apparent at lower dilutions of virus (Fig. 
V.l).
The infectivity ratios produced in HRT-18 parent cells were nearly
-2 -5identical with and without trypsin at BCV-L9 dilutions of 10 - 10
At the 10  ^dilution of inoculum, an increase in PFU:HA of 5 log units
was obtained (Fig. V.2).
The infectivity of BCV-L9 propagated in the HRT-18 clones was less
dramatically affected by trypsin, but definite trends in virus yields
were observed. At the 10  ^dilution of L9 propagated in clone 3F3, an
increase in PFU:HA of about 1 log unit occurred in the presence of
trypsin. A consistent increase in the infectivity ratio did not occur
at lower dilutions (Fig. V.3). Clone D2 produced a PFU:HA that was ■
increased by 1/3 log with trypsin at the 10 ^ dilution, and this slight
increase persisted at 10 ^ dilution (Fig. V.4). The infectivity ratios 
-2 -3at the 10 and 10 dilutions were 1/2 to 1 log lower with trypsin in
clone 3E3. However, continuing the trend shown by all other cell types, 
-4 -5at 10 and 10 dilutions of inoculum, the trypsin-treated sets
produced slightly elevated PFU:HA. No detectable virus was produced
when the dilution was 10 ^ (Fig. V.5). A reverse trend occurred when L9
was propagated in clone 4B3 with or without trypsin. At the highest
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dilution, an infectious yield of nearly 1 log unit higher occurred in
the absence of trypsin (Fig. V.6).
The wild-type strain LY-138 propagated in HRT-18 parent cells showed
-2 —5no enhanced infectivity at dilutions 10 - 10 . A 1/2 log increase
was evident in the presence of trypsin at the 10  ^dilution (Fig. V.7).
Figure V.8. shows the PFU:HA ratios with trypsin:without trypsin 
obtained in each cell type at the highest dilution producing detectable 
virus - the limiting virus dilution. The ratios were 5:1, 2:1, and 3:1 
for clones 3F3, D2, and 3E3 respectively, and less than 1 for 4B3. 
Infinitely enhanced yields were produced by D2BFS and HRT-18 parent 
cells in the presence of trypsin.
The PFU:HA ratios with:without trypsin were calculated for each cell 
type at all dilutions of inoculum and are displayed graphically in 
Figure V.9. The purpose of this graph is to simplify the comparison of 
the effects of trypsin on viral infectivity between the different cell
types. Infinitely enhanced infectivity was apparent in D2BFS cells at
-4 . . . .the 10 inoculum dilution. This dilution represents an initial MOI of
-43 x 10 PFU/cell. HRT-18 cells produced infinitely enhanced viral
infectivity in the presence of trypsin at the 10  ^dilution (initial MOI
of 3 x 10  ^PFU/cell). Therefore, enhanced viral infectivity occurred
at a 1000-fold higher MOI in D2BFS cells. When L9 was propagated in
HRT-18 clones D2 and 3E3, trypsin enhancement of viral infectivity was 
-4evident at the 10 dilution. A detectable increase in infectious virus 
yields was evident in clone 3F3 cells at 10 ^ dilution, but at the same 
dilution infectious yields were decreased by trypsin whei. L9 was assayed 
from clone 4B3.
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V.C.2. Effect of Different Trypsin-Treatment Schemes on Virus Yields 
The yields of infectious virus produced in D2BFS cells under 
different trypsin-treatment conditions was titrated in quadruplicate by 
plaque assay in HRT-18 cells. These data are displayed as i°gjQ PFU in 
Figure V.10. The PFU counts were essentially the same for pretreated 
cells (set 1) and the control system (set 5). Nearly identical 
infectious yields were obtained when trypsin was added to infected cells 
post infection (set 2) and when the inoculum was pretreated, then 
trypsin was added post infection (set 4). These values were 
significantly higher than those obtained from sets 1 and 5 (F = 134.56, 
p<0.0001). The lowest yield was obtained from set 3 (inoculum 
pretreated with trypsin, then soybean trypsin inhibitor). This set was 
significantly lower than all other treatments.
V.D. DISCUSSION
The effect of trypsin on BCV infectivity was quantitated by 
determining PFU:HA. This ratio represents the amount of infectious 
virus per heraagglutinating unit obtained from a given sample. This
method of quantitation was chosen over a simple PFU titration because it
depicts the effect of trypsin on the entire virus population. These
data represent consistent trends and are reported as such.
Trypsin enhanced the infectivity of BCV-L9 propagated in HRT-18 
parent and D2BFS cells to infinite proportions. The increase in 
infectivity was apparent at a 100-fold lower inoculum dilution 
(1000-fold higher MOI) in D2BFS cells. L9 propagated in the HRT-18 
clones exhibited differences in the amount of trypsin enhancement and 
the dilution at which the increased yields appeared. A plausible
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explanation for these phenomena is that bovine coronaviruses require 
proteolytic processing to activate their infectious potential. In a 
given cell type, the pool of progeny virus consists of two forms of 
virus - infectious and noninfectious, reflecting the cell's ability to 
process the virus to the infectious form by endogenous protease. With 
dilution the supply of infectious virus in the inoculum is minimized, 
emphasizing the cell's ability to produce infectious virus. Trypsin 
converts noninfectious progeny virus to the infectious form, thereby 
enhancing the infectivity of the virus yield. Therefore, cells with a 
high capacity for production of infectious progeny require a higher 
dilution of inoculum before trypsin enhancement is apparent. If the 
ratio of infectious virus exceeds noninfectious virus, then trypsin 
enhancement is not detectable. Such an event would explain the marginal 
trypsin effect in the HRT-18 clones. It is likely that HRT-18 parent 
cells are innately capable of producing high yields of infectious BCV, 
unlike D2BFS cells, which require the addition of trypsin for activation 
of the virus. It is evident from these investigations that trypsin-like 
proteases are required to activate the infectivity of BCV in some 
cultured cells.
Interestingly, the effect of trypsin on the infectivity of L9 
correlates well with the results of the cytological studies described in 
the preceding chapters. The CPE produced in D2BFS and HRT-18 cells was 
enhanced by trypsin, and the four HRT-18 clones varied in response to 
trypsin treatment. Clone 4B3, which was only minimally affected by L9 
with or without trypsin, was the only cell line to produce lower 
infectious yields in the presence of trypsin. The molecular basis for 
this finding is not fully understood.
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LY-138 was slightly enhanced in infectivity when propagated in 
HRT-18 cells, as compared to the dramatic increase shown with L9. 
Williams (132) found differences in the protein profiles of 
trypsin-treated L9 and LY-138, although their untreated profiles were 
nearly identical. This indicated that the two strains are cleaved 
differently, a trait which may account for differences in the infectious 
potential of the viruses.
Different trypsin-treatment conditions of L9-infected D2BFS cells 
were employed to discern the target of trypsin action. It was found 
that pretreatment of cells with trypsin had no effect on the production 
of infectious virus. It was concluded that any putative effect that 
trypsin exerted on the host cell did not affect virus production. On 
the other hand, the presence of the enzyme in culture medium enhanced 
the virus titer. In this case, trypsin had access to the progeny virus 
and probably activated noninfectious particles to the infectious form as 
previously discussed. Trypsin alters the polypeptide profile of BCV 
(133), so it was considered likely that the effect would be exerted 
directly on the virus. However, pretreated inoculum produced the lowest 
yields of all 5 sets. Soybean trypsin inhibitor was not removed from 
the system in this set. Potential deleterious effects of the inhibitor 
on the host cells or virus were not examined, but may have contributed 
to the low yield.
From these studies it can be concluded that the infectivity of BCV 
is dependent upon the host cell and trypsin modification. Trypsin is a 
constituent enzyme of the intestinal tract, the site of BCV replication 
in the natural host. Therefore, it may play a role in activation of 
.virulent virus in natural infections. Factors causing variance in BCV
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replication between cell types are unknown and must be assessed to fully 
understand the mechanism of BCV infectivity in culture. Frana and 
coworkers (37) found the murine coronavirus MHV-A59 to be dependent on 
the host cell or trypsin treatment for activation of the cell-fusing 
activity of the virus. Proteolytic activation of infectivity has been 
well documented in paramyxoviruses, orthomyxoviruses, and rotaviruses as 
well (25,35,39,51-54,74,92,99,106).
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Figure V. 2. Infectivity Ratios of BCV-L9 Propagated in
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Figure V. 5. Infectivity Ratios of BCV-L9 Propagated in Clone
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CHAPTER VI. EFFECT OF THE HOST CELL AND TRYPSIN TREATMENT ON THE
POLYPEPTIDE PROFILE OF BCV-L9
IV.A. INTRODUCTION
Proteolytic cleavage of inactive precursor polypeptides of assembled
virions into an active form is necessary for inducing the infectivity of
a number of viruses. Notably, orthomyxoviruses and paramyxoviruses
require cleavage of envelope proteins for the viruses to become
infectious (24,25,39,51,52,54,92,93). Such findings are emerging for
coronaviruses as well. Processing of the viral proteins is accomplished
either by cellular proteases or by exogenous proteases, such as trypsin.
Frana et al (37) found that processing of the 180 Kd glycoprotein of
MHV-A59 was host cell-dependent and affected the functional capacity of
the virus. Those cells which fully cleaved the 180 Kd protein to its 90
Kd subunits activated rapid cell fusion. Cells which cleaved the
protein incompletely required trypsin to activate rapid cell fusion.
Trypsin enhances the replication and cytopathic expression of bovine
coronaviruses. In Chapter IV it was shown that fusion of BCV-L9-
infected D2BFS cells required trypsin, but the protein responsible for
cell fusion has not been determined.
Williams and Storz (133) detected two phenotypes of virus when
BCV-L9 was purified from HRT-18 cells by isopycnic centrifugation in
sucrose or CsCl gradients. The dense and light forms of the virus had
3densities of 1.255 and 1.223 g/cm , respectively. The two virus forms 
had distinct polypeptide profiles, and the light form was converted to 
the dense form by in vitro trypsin treatment.
There were three objectives to this investigation. The first 
objective was to assess putative cell-dependent differences in the
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protein composition of BCV-L9. The virus was raised in HRT-18 parent 
cells, HRT-18 clones 3F3, D2, 3E3, and 4B3, and in D2BFS cells, since 
these cells display different cytopathic effects when infected with the 
virus. The second objective was to compare the protein profiles of in 
vitro trypsin-treated or untreated L9 propagated in HRT-18 cells. The 
profiles were examined under reducing and non-reducing conditions to 
assess the effect of the enzyme on the viral polypeptides. Assessment of 
the structural proteins of BCV-L9 propagated in D2BFS cells in the 
presence or absence of trypsin by Western blotting was the third 
objective. Cell fusion occurs with infected D2BFS cells only in the 
presence of trypsin. This technique was employed to identify the viral 
protein(s) responsible for cell fusion.
VI.B. MATERIALS AND METHODS
VI.B.l. Cells and Virus
HRT-18 parent cells and four HRT-18 clones, 3F3, D2, 3E3, and 4B3
2 . 2were grown in 850 cm Corning roller bottles or in 150 cm flasks. When
seeded in roller bottles, DMEM containing 25 mM Hepes and 12 mM NaHCO^
was used to stabilize pH. After 1 day incubation at 37°C, this medium
was replaced with standard DMEM (described in Chapter III). D2BFS cells
2
were grown in MEM in 750 cm glass roller bottles. BCV-L9 was the virus 
strain used in these studies.
VI.B.2. Virus Propagation and Purification
Cells were infected with BCV-L9 at an MOI of 0.01-0.1 PFU/cell. 
Following adsorption for 1 h at 37°C, excess inoculum was removed and 
cells were washed three times with Dulbecco's PBS. Medium was added, 
and cells were incubated at 37°C. MEM containing 5 ug/ml trypsin was
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added to bottles of infected D2BFS cells. When CPE affected 
approximately 80% of the monolayer, cells were frozen at -70°C. Bottles 
were thawed; the infected material was pooled into 250 ml centrifuge 
bottles, sonicated, and refrozen.
Virus was purified from thawed cell lysate according to a 
modification of the procedure described by Wege et al (128). All steps 
were done at 4°C. NaCl was added to the collected fluid to a final 
concentration of 0.5 M. Culture fluid was clarified by centrifugation 
at 10,000 x g for 20 min. 30% polyethylene glycol - 8000 was added to 
the clarified supernatant to a final concentration of 10%, and mixed on 
ice for 10 min. The resulting precipitate was sedimented by 
centrifugation at 10,000 x g for 30 min. The precipitate was collected 
in TNE buffer (0.01 M Tris-HCl, 0.01 M NaCl, 0.001 M EDTA) pH 7.4, 
resuspended by sonication, and dispersed by Dounce homogenization. The 
slurry was centrifuged at 1000 x g for 10 min. to remove aggregates.
The suspension was centrifuged through a continuous 5-20% sucrose-TNE 
gradient onto a 4 ml 60% cushion at 70,000 x g for 2 h. The band at the 
20-60 % interface was collected, diluted to less than 20% with TNE 
buffer, and layered onto a continuous 20-60% sucrose-TNE gradient.
Tubes were centrifuged at 55,000 x g for 16-18 h. Gradient fractions 
were collected by puncturing the bottom of the centrifuge tubes. 
Virus-containing bands were identified by hemagglutinating activity. 
Fractions containing the highest HA titers were pooled and concentrated 
by pelleting through a 5 ml 20% sucrose cushion for 2 h at 90,000 x g. 
Virus was resuspended in TNE buffer. The virus suspension was layered 
onto a preformed CsCl-TNE gradient (1.0606 - 1.2886 g/cm ) and
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centrifuged at 55,000 x g for 20 h to further purify the virus. Bands 
were collected as described above, concentrated, and resuspended in TNE.
VI.B.3. Partial Purification or Concentration of Virus.
Partially purified or concentrated virus was of adequate purity for
immunoblot analyses. Virus was propagated in HRT-18 clones grown in
2
roller bottles or 150 cm flasks. To partially purify the virus, 
centrifuge bottles of pooled cell lysate were thawed, then clarified at 
10,000 x g for 20 min. at 4°C. Supernatant fluid was loaded onto 
continuous 5-20% sucrose-TNE gradients and centrifuged at 70,000 x g for 
2 h. The resulting pellet was resuspended in TNE buffer, loaded onto 
continuous 20-60% sucrose-TNE gradients, and centrifuged at 55,000 x g 
for 16-20 h. Bands were collected, concentrated, and resuspended as 
described.
To minimize loss of virus, L9 was directly concentrated from D2BFS
2cells. D2BFS cells in 150 cm flasks were infected with BCV-L9 at an 
MOI of approximately 0.1 PFU/cell. After adsorption, cells were washed 
well to remove unadsorbed virus. MEM was added to one set of flasks, 
and MEM with 5 ug/ml trypsin (Difco 1:250) was added to the other set. 
Flasks were incubated at 37°C for 3 days, then frozen, thawed, and the 
cell lysate was pooled. Fluid was clarified at 10,000 x g for 20 min. 
to remove cell material. The supernatant was centrifuged through a 5 ml 
20% sucrose-TNE cushion for 2 h at 90,000 x g. The pellet was 
resuspended in TNE, concentrated, and resuspended as described.
VI.B.4. Preparation of Uninfected Cell Antigen for Western Blots
2
Washed cells in 150 cm flasks were frozen at -70°C, then thawed, 
and cell material was collected in centrifuge tubes. Cell material was
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sonicated for 1 min., then the suspension was centrifuged at 1000 x g 
for 15 min. to settle nuclei. The supernatant was centrifuged at 90,000 
x g for 2 h, and the pellet was resuspended in TNE buffer.
VI.B .5. In Vitro Trypsin Treatment
Aliquots of partially purified virus preparations were treated with 
1 ug/ml of highly purified trypsin (Sigma, TPCK treated) in Dulbecco's 
PBS at 37°C for 30 min. The action of trypsin was stopped by the 
addition of 1 ug/ml soybean trypsin inhibitor (Sigma) and incubation at 
4°C for 30 min. The virus suspension was centrifuged through a 2 ml 20% 
sucrose-TNE cushion at 90,000 x g for 2 h. Pellets were resuspended to 
original volume in TNE.
VI.B.6. Protein Quantitation
Protein concentrations were initially determined using the 
protein-dye binding technique developed by Bradford (10). The BioRad 
Automated Protein Assay was employed in later experiments because this 
technique required less sample to quantitate the protein. In addition, 
the procedure was simpler to perform, and the results were read more 
rapidly.
VI.B.7. Polyacrylamide Gel Electrophoresis (PAGE)
SDS-PAGE of virus samples was done using the Laemmli buffer system 
(65). Samples were dissociated by diluting 1:2 or 1:3 in buffer 
containing B-mercaptoethanol, a reducing agent, or in the same buffer 
lacking the reducing agent, then boiling for 5 min. Gels containing 10% 
or 12% bis-acrylamide were prepared in 1 mm thicknesses. Gels were run 
at a constant power of 4 watts/gel (approximately 25 mA/gel) for 3-4 h.
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BioRad low and high molecular weight standards were used: lysozyme
(14,400), soybean trypsin inhibitor (21,500), carbonic anhydrase 
(31,000), ovalbumin (45,000), bovine serum albumin (66,200), 
phosphorylase B (92,500), B-galactosidase (116,250), myosin (200,000). 
Proteins were visualized using the BioRad silver stain kit developed 
according to the procedure of Merrill et al (86). The Coomassie blue 
protein stain was used in combination with the silver stain to identify 
proteins which did not stain with silver.
VI.B.8. Immunoblot Procedures
Immunoblots (Western blots) were done according to the procedure of 
Burnette (16). Briefly, proteins were separated by SDS-PAGE and 
transferred to nitrocellulose membranes using Tris-glycine transfer 
buffer (20 mM Tris base, 150 mM glycine), pH 8.3. Transfer was 
essentially complete after 18-20 h at 35 volts at approximately 10-15°C. 
Transferred proteins were stained with Ponceau S (91), and molecular 
weight markers were cut off and saved for use in determining molecular 
weights of viral proteins. Viral proteins were detected as follows: 
Nitrocellulose membranes were immersed for 1-4 h in blocking solution 
consisting of 5% Blotto (60) in Tris buffered saline (TBS) consisting of 
10 mM Tris base and 0.9% NaCl, pH 7.4. Primary antibody consisting of 
anticoronavirus serum, obtained from an experimentally infected calf, in 
TBS with 1% Blotto was added and allowed to incubate 16-18 h. Excess 
antibody solution was removed, and nitrocellulose was washed three times 
for 5 min. each using TBS containing 0.05% Tween 20. Goat antibovine 
IgG (H + L chain), peroxidase conjugated, was obtained from Kirkegaard 
and Perry Laboratories and diluted 1:5 in ELISA PBS + 0.1% human
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albumin. The conjugate was diluted to a final concentration of 1:1000 
in TBS, added to the membrane, and incubated for 2 h. The membrane was 
washed as described, and substrate consisting of 15 mg 4-chloronapthol 
in 5 ml methanol, 25 ml 0.05 M Tris pH 6.8, 12 ul was added. After
optimal color development had occurred, the reaction was stopped by 
rinsing with distilled water.
VI.C. RESULTS
VX.C.l. Comparison of the Polypeptide Structure of BCV-L9 Propagated in 
Different Cells
The polypeptide composition of purified BCV-L9 propagated in D2BFS 
cells with trypsin or in HRT-18 cells is revealed in Figure VI.1. 
Proteins were visualized by double staining with silver followed by 
Coomassie blue. Coomassie blue was used to stain proteins which did not 
stain with the silver reagent. The profiles are compared in Table VI.1. 
Common proteins of 140, 100, 52, 37, 34, 26, and 18-23 Kd were present 
under non-reducing conditions, and a 62 Kd protein was present in D2BFS- 
propagated virus. Distinctly different profiles were obtained under 
reducing conditions. In addition to common proteins of 95, 65, 52, 37, 
34, 26 and 18-23 Kd, L9(HRT-18) had a 46 Kd protein that was not 
observed in L9 (D2BFS). The reduced profile of L9 (D2BFS) had unique 
proteins of 93, 71, and 62 Kd.
The protein composition of partially purified BCV-L9 from HRT-18 
cells and concentrated L9 from D2BFS cells without trypsin was detected 
by Western blots (Fig. VI.2). This technique allowed the detection of 
high molecular weight proteins not observed by silver staining, since 
higher concentrations of virus were used with the immunoblot procedure.
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The structural proteins of L9 produced in the two cell lines are 
compared in Table VI.2. Common proteins of 185, 140, 100, 52, 37, and 
31-34 Kd were observed. Notable differences included the following: A 
>200 Kd protein was found in D2BFS-produced virus, but not in virus 
obtained from HRT-18. This protein may be an uncleaved precursor or an 
aggregate of viral proteins. A 160 Kd protein was present in the L9 
(D2BFS) profile but not L9 (HRT-18). However, this protein was present 
in the profile of L9 obtained from other HRT-18 parent and clone 
preparations, and probably was not detected due to the concentration of 
sample on the gel. Interestingly, the 185 Kd protein was present in 
high concentration in L9 (D2BFS), but in proportion to the other 
proteins comprising the profile, it was present in low concentration in 
L9 (HRT-18). The 46 Kd protein was not detected in the HRT-18 
preparation in this instance.
L9 was propagated in the four HRT-18 clones, partially purified, and 
the proteins were separated by SDS-PAGE. Immunoblotting was the method 
used to detect these proteins (Fig. VI.3). Under non-reducing 
conditions common proteins of 185, 160, 140, 125, 100, 52, 46, 37,
31-34, and 26-28 Kd were fo'und in virus produced in clones 3F3, D2, and 
3E3 (Table VI.3). The 46 Kd protein was absent in L9 prepared from 
clone 4B3. Doublet bands of 110 and 100 Kd were found with L9 obtained 
from clones 3F3, 3E3, and 4B3, whereas only a single 100 Kd band was 
present in L9 from clone D2. The profiles of L9 propagated in clones D2 
and 3F3 are compared in Figure VI.4. to better illustrate this finding.
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VI.C.2. Effect of Reducing Conditions on the Polypeptide Profile of 
BCV-L9
Proteins of 140 and 100 Kd were consistently present in BCV-L9 
preparations under non-reducing conditions. The silver staining 
technique revealed that these proteins disappeared under reducing 
conditions with the concomitant appearance of 95 and 65 Kd proteins 
(Figs. VI.1 and 6). Three distinct bands of 23, 20, and 18 Kd were 
converted to a cluster of bands ranging from 20-23 Kd by reducing agent 
(Fig. VI.6).
The effect of reducing agent on the L9 profile was also examined by 
Western blot, but this method failed to detect all reduced products 
accurately (Fig. VI.3). The proteins of 185, 160, 140, 125, 110, and 100 
Kd were not seen under reducing conditions and proteins of 190 and 65 Kd 
were evident (Table VI.3).
VI.C.3. Effect of Trypsin on BCV-L9 Polypeptides
BCV-L9 was propagated in D2BFS cells in the presence and absence of 
trypsin. Cell lysates were clarified and concentrated, and the viral 
proteins were separated by SDS-PAGE under non-reducing conditions. 
Following their transfer to a nitrocellulose membrane, viral proteins 
were visualized by Western blotting (Fig. VI.5.). Virus propagated 
under trypsin-free conditions had the following profile: >200, 185,
140, 100, 52, 46, 37, and a 31-34 Kd cluster. The 185 Kd protein was 
only faintly visible, the 160 Kd protein was not apparent, and the 100 
Kd protein was present in higher concentration in L9 produced in D2BFS 
in the presence of trypsin. An additional difference between the 
profiles was the absence of the 31-34 Kd cluster in trypsin-treated 
virus.
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L9 was propagated in HRT-18 cells and purified, then treated in 
vitro with trypsin. The profiles of untreated and trypsin-treated L9 
were examined under non-reducing and reducing conditions (Fig. VI.6).
The structural proteins observed under these conditions are compared in 
Table VI.4. In the absence of reducing agent, the profiles were 
identical. Detectable bands had molecular weights of 140, 100, 52, 27 
23, 20, and 18 Kd. Differences in the electrophoretic migration of 
trypsin-treated and untreated viral proteins were evident only under 
reducing conditions. A 95 Kd protein was found in untreated virions, 
while a 90 Kd protein was found in trypsin-treated virions.
Additionally, a cluster of 20-23 Kd proteins was found in untreated 
virions, but this cluster ranged from 19-23 Kd with a 17 Kd protein in 
trypsin-treated virions.
BCV-L9 propagated in clones 3F3 and 4B3 was treated in vitro with 
trypsin and the profiles of trypsin-treated and untreated virus were 
compared under non-reducing conditions (Fig. VI.7.). The profile of L9 
from clone 4B3 was unchanged with trypsin treatment. Trypsin-treated L9 
from clone 3F3 lacked the 46 Kd protein present in untreated virus. In 
addition, a band of approximately 25 Kd appeared. The profiles of 
trypsin-treated and untreated L9 from clone 3F3 were also compared under 
reducing conditions (Fig. VI.8.). Again the 46 Kd protein was absent 
from trypsin-treated virions, and the 25 Kd protein was evident. The 
effect of trypsin on the high molecular weight proteins was undetermined 
since these proteins were not readily detectable under reducing 
conditions. The effect of trypsin on the non-reduced profiles of L9 in 
D2BFS cells, clone 3F3, and clone 4B3 are compared in Table VI.5.
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VI.D. DISCUSSION
Host cell-dependent differences in the polypeptide profile of BCV-L9
were demonstrated in this investigation. Notably, a 62 Kd protein was
evident by silver stain in a preparation of L9 propagated in D2BFS cells
with trypsin. Trypsin was used in the propagation to increase the yield
of virus from D2BFS cells. The 62 Kd protein may represent a cell-
specific viral protein or a trypsin cleavage product. Western blot
analyses of L9 (D2BFS) preparations failed to detect this protein. A
110-100 Kd doublet band was detected in L9 propagated in clones 3F3,
3E3, and 4B2, but only the 100 Kd species was evident from clone D2.
This difference may reflect a variation in processing or in
glycosylation of the protein. A major protein of 46 Kd was evident in
virus raised in all cells except clone 4B3, which lacked the protein.
The function of this protein species is unknown, but the absence of the
protein may be the reason that relatively mild cytopathic expression
occurs in infected clone 4B3 (Chapters 3 and 4).
Storz and coworkers (unpublished results) detected host cell-
dependent differences in the polypeptide profile of BCV-L9 by
radioiramune precipitation. The virus was propagated in different cell
types in medium containing [^C] - labeled amino acids or [^S] -
methionine. The proteins detected when the virus was propagated in
HRT-18 cells included 180, 82, 47, and 35 Kd species. Using [^C] -
labeled amino acids, BCV from bovine fetal thyroid cells had proteins of
140, 100, 70, 52, and 47 Kd, while viruses propagated in the same cells
35in the presence of [ S] - methionine had an 80 Kd migrating protein 
species instead of the 70 Kd species. BCV propagated in bovine fetal
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brain cells in the presence of [^C] - labeled amino acids or [^S] - 
methionine had a composite profile of 140, 100, 60, 52, and 47 Kd.
Silver-stained gels revealed that the 140 and 100 Kd protein that 
were present under non-reducing conditions disappeared under reducing 
conditions. At the same time, proteins of 95 Kd and 65 Kd appeared in 
the presence of reducing agent. Hogue and coworkers (46) found that the 
140 Kd species consists of disulfide-linked subunits of 65 Kd. They did 
not observe a change in the electrophoretic migration of the 100 Kd 
species under reducing conditions. The 18, 20, and 23 Kd group of 
proteins was converted to a 20-23 Kd cluster by reduction. Western 
blotting also revealed a change in the electrophoretic mobility of the 
185 Kd protein to 190 Kd under reducing conditions. Rather than 
consisting of disulfide-linked subunits, the 185 and 100 Kd molecules 
and the 18-23 Kd group of proteins probably contain intrachain disulfide 
bonding. In this case, reduction may alter the migration pattern by 
breaking the intrachain bonds and allowing the proteins to be coated by 
SDS more efficiently. Consequently, the conformation of the intact 
proteins would be different under reducing and non-reducing conditions, 
which would influence the electrophoretic migration.
Silver staining was a superior method to Western blotting for the 
detection of reduced L9 proteins. An extended reaction time in the 
substrate was required to visualize reduced proteins by Western 
blotting. The long incubation in substrate led to a high background and 
made it difficult to discern the viral protein bands. It was impossible 
to determine the relationship between non-reduced and reduced proteins 
by this method. Since Western blotting depends on the antigenicity of
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proteins, it is likely that the viral proteins were antigenically
altered when their conformation was changed by reduction.
The non-reduced form of virus is the disease agent in natural 
infections of calves. Therefore, it was considered more important to 
examine the non-reduced profile of BCV. The use of antiserum obtained 
from an experimentally infected calf in Western blot procedures 
indicated the antigenically active components of the virus.
Interestingly, the action of trypsin on the virus structure was 
evident by silver stain only under reducing conditions. This finding 
indicates that trypsin-cleaved peptides were held intact by disulfide 
bonds. When reduced by B-mercaptoethanol, cleavage products were 
separable. Unique proteins of 93, 71, and 62 Kd were detected in 
preparations of L9 from D2BFS cells + trypsin. Trypsin-dependent bands
of 90 Kd and 17 Kd were detected in L9 (HRT-18), and the 20-23 Kd
cluster found in untreated virions was converted to a 19-23 Kd cluster 
by trypsin (Table VI.4). In vitro trypsin-treated and untreated L9 from 
clone 4B3 gave identical profiles. Trypsin-treated L9 from clone 3F3 
differed from untreated virus - the 46 Kd protein was not present in 
treated virions, but a 25 Kd protein was found. The 46 Kd protein must 
be a surface component since it was accessible to trypsin. The 
relationship between the 46 and 25 Kd proteins has not been determined 
conclusively, but the 25 Kd protein may be a cleavage product of the 46 
Kd species. Trypsin greatly enhances the cytopathic expression of L9 in 
clone 3F3, but has little effect on the cytopathic changes of infected 
4B3 cells (Chapters III and IV). The cytopathic changes may be a 
reflection of the trypsin-induced changes in polypeptide structure 
observed here.
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The effect of trypsin on the polypeptide structure of L9 propagated 
in D2BFS cells was examined because these cells fuse only in the 
presence of trypsin. The intent was to identify the viral protein(s) 
responsible for cell fusion. Under non-reducing conditions the 185 Kd 
protein was present in high concentration in the absence of trypsin, but 
only a faint band was present in virus produced with trypsin. The 160 
Kd protein was barely evident without trypsin and not seen with trypsin. 
Concomitantly, the concentration of the 100 Kd species was much higher 
in the presence of trypsin. No additional proteins were found in virus 
propagated with trypsin, but trypsin cleavage may have affected the 
antigenicity of some proteins so that they were undetectable by Western 
blotting. For example, silver staining detected a 62 Kd protein when L9 
was propagated in D2BFS cells with trypsin, but the protein was not 
evident by Western blot detection. These data strongly suggest that 
cleavage of the 185 Kd protein to the 100 Kd form and/or other 
undetected smaller species is required for activation of cell fusion.
In Fig. VI.2. the profiles of the virus raised in HRT-18 and D2BFS are 
compared. The 185 Kd species is present in proportionately low 
concentration in L9 (HRT-18) as compared to L9 (D2BFS). The protein was 
also found in low concentration in virus obtained from the four clones. 
Evidently, cleavage of ,the 185 Kd protein occurs by a cellular protease 
in HRT-18 cells, while cleavage is less efficient in D2BFS cells. These 
cells require trypsin to cleave this protein and activate fusion. This 
finding is analogous to the MHV model. With MHV-A59 a 180 Kd protein 
must be cleaved by a cellular protease or by trypsin to activate the 
fusing capacity of the virus (37,119).
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It appears that clone 4B3 is capable of cleaving the 185 Kd protein 
(Fig. VI.2), but this cell line does not fuse. The lack of fusion in 
clone 4B3 may be a result of the composition of the plasma membrane of 
these cells or other cellular characteristics, rather than the manner in 
which these cells process the virus.
The 160 Kd protein may also be cleaved by trypsin since it was not 
evident in the presence of trypsin. However, the concentration of this 
protein was so low in the absence of trypsin that its cleavage would not 
have caused the dramatic increase in concentration of the 100 Kd 
species. It is possible that cleavage products of the 160 Kd protein 
were not detectable. In addition, a 31-34 Kd group of proteins was 
found in the absence of trypsin, while a single 34 Kd species was found 
in virus produced with trypsin. These proteins must represent external 
proteins since they were accessible to the enzyme.
Western blot detection allowed the identification of at least eleven 
BCV-L9 structural proteins from HRT-18 cells. The proteins include the 
following approximate molecular weight species: 185 Kd, 160 Kd, 140 Kd,
125 Kd, 110 Kd, 100 Kd, 52 Kd, 46 Kd, 37 Kd, a 31-34 Kd group, and a 
26-28 Kd cluster. The 52 Kd species was the predominate protein. The 
140 and 125 Kd proteins were closely migrating species, as were the 110 
and 100 Kd proteins. When these proteins were present in high 
concentration, as with L9 (D2BFS) (Figs. VI.2. and 5), or when poor 
separation of high molecular weight proteins occurred, these proteins 
were not resolved as individual species. Rather, single, broad bands of 
approximately 140 and 100 Kd were detected.
A group of proteins of 18-23 Kd was apparent on silver-stained 12% 
gels under non-reducing conditions, while a concise cluster of 20-23 Kd
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was detected on reduced gels. These proteins were not detected on 10% 
gels by Western blot. The 26-28 Kd proteins detected by Western blot 
and the 18-23 Kd proteins detected by silver stain may represent the 
same proteins with different migration patterns in 10 and 12% gels.
Hogue and coworkers (46) used a 5-15% gradient gel to pinpoint the
molecular weight of this cluster at 26 Kd.
The polypeptide profile of BCV-L9 propagated in HRT-18 cells was 
also examined by other investigators (46,63,64,133). The structural 
proteins reported by these investigators, as well as those identified in 
this study are compared in Table VI.6. David Brian's group detected 
high molecular weight species of 190, 140, 120, and 100 Kd. These 
proteins were identified as surface glycoproteins, with gp 140 serving 
as hemagglutinin (64). The investigators found that the 140 Kd species 
consisted of disulfide-linked subunits of 65 Kd, a finding supported by 
this investigation. Hogue and coworkers (46) observed a 160 Kd band 
which reacted with antiserura against pp 52. They suggest that this 
protein represents a trimer of the 52 Kd species. Williams (133) 
reported high molecular weight proteins of 182 and 109 Kd in light
virions and 172 and 94.5 Kd in dense virions. Both profiles were
obtained under reducing conditions, making it difficult to compare these 
profiles to those obtained in the present study.
A 52-53 Kd major protein was identified in all investigations of BCV 
structure (46,63,64,133). This protein is an internal phosphoprotein 
which probably serves as nucleocapsid. The nucleocapsid of nearly all 
coronaviruses is a phosphoprotein of 48-52 Kd.
A cluster of proteins of approximately 26 Kd was reported by the 
three groups of investigators. King et al (64) demonstrated that this
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molecule is a surface glycoprotein, probably serving as a matrix 
protein. The clustering of the protein presumably indicates 
glycosylation isomers with slightly varying molecular weights. The 
matrix protein of most coronaviruses is a glycoprotein of 20-29 Kd.
Additional proteins of 46, 37, and 31-34. Kd were also observed. The
functions of these protein are unknown. The 46 and 31-34 Kd proteins
were cleaved by trypsin, indicating that they are external proteins. 
Williams (133) reported common proteins of 47 and 35 Kd in dense and 
light virions. A 20.5 Kd species was detected in light virions, and 21 
and 15 Kd species were identified in dense virions. Similar proteins 
were detected in this study when the profiles were examined by silver 
stain. Dense and light forms of L9 were not separated in this 
investigation. Therefore, these analyses represent a composite of both 
the dense and light profiles, probably contributing to the greater 
complexity of the profiles detected in this study.
The MHV virion was thought to consist of only three structural 
proteins originally - a 180 Kd peplomeric glycoprotein, a 50 Kd
nucleocapsid phosphoprotein, and a 23 Kd matrix glycoprotein. Recently, 
Sturman and coworkers (119) demonstrated that the 180 Kd protein is 
actually comprised of two 90 Kd subunits, 90A and 90B, that are 
distinctly different species. Obviously, MHV is a more complex virus 
than originally described, and further examination may reveal even 
greater complexity. In contrast, our investigation revealed at least 
eleven structural proteins for BCV-L9. The protein profiles depended on 
the host cell used to propagate the virus and the detection system 
applied. For example, proteins of greater than 140 Kd were not detected 
in silver-stained gels due to a low concentration of protein on the gel.
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Conversely, the 140 and 125 Kd proteins appeared as a single band from 
D2BFS preparations since the high concentration of the proteins did not 
allow them to be resolved separately. There were differences in the 
BCV-L9 profile obtained in this investigation as compared to those 
reported by Williams (133), Hogue and coworkers (46), and King and 
coworkers (63,64). Obviously, the protein composition of this virus is 
still unsettled.
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Table VI.1. Polypeptide Profile of BCV-L9 Purified from HRT-18 or D2BFS 
Cells as Detected by Silver Staining.
L9 (HRT-18) L9 (D2BFS + trypsin)
reduced non-reduced reduced non-reduced
95
65
140
100
52
46
37
34
26
18-23
52
46
37
34
26
18-23
95
93
71
65
62
52
140
100
62
52
37
34
26
18-23
37
34
26
18-23
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Table VI.2. Comparison of the Structural Proteins of BCV-L9 Obtained 
from HRT-18 and D2BFS Cells under Non-reducing Conditions as Detected by 
Western Blotting.
L9 (D2BFS) L9 (HRT-18)
>200
185 185
160
140 140
100 100
52 52
46
37 37
31-34
f
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Table VI.3. Structural Proteins of BCV-L9 from HRT-18 Clones as 
Detected by Western Blotting.
Non-reducing Conditions Reducing Conditions
D2 3E3 3F3 4B3 D2 3E3 3F3 4B3
185 185 185 185 190 190 190 190
160 160 160 160
140 140 140 140
125 125 125 125
- 110 110 110
100 100 100 100 65 65 65 65
52 52 52 52 52 52 52 52
46 46 46 - 46 46 46 -
37 37 37 37 37 37 37 37
31-34 31-34 31-34 31-34 31-34 31-34 31-34 31-34
26-28 26-28 26-28 26-28 26-28 26-28 26-28 26-28
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Table VI.4. Effect of Trypsin on the Polypeptide Profile of BCV-L9 
Propagated in HRT-18 Cells as Detected by Silver Stain.
Trypsin (-) Trypsin (+)
Reduced Non-reduced Reduced Non-reduced
- 140 - 140
- 100 - 100
95 ■ - 90 -
65 - 65 -
52 52 52 52
46 - 46 -
37 37 37 37
34 34 34 34
31 27 31 27
- 23 19-23 23
20-23 20 17 20
18 18
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Table VI.5. Effect of Trypsin on the Non-reduced Polypeptide Profile of 
BCV-L9 Propagated in Different Cells as Detected by Western Blotting.
L9
Trypsin(-)
(D2BFS)
Trypsin(+)
L9
Trypsin(-)
(3F3)
Trypsin(+)
L9
Trypsin(-)
(4B3)
Trypsin (+)
>200 -
185 - 185 185 185 185
160 - 160 160 160 160
140 140 140 140 140 140
125 125 125 125
110 110 110 110
100 100* 100 100 100 100
52 52 52 52 52 52
46 46 46 - - -
37 37 37 37 37 37
31-34 31-34 31-34 31-34 31-34 31-34
25
* Increased in concentration
fTable VI.6. Comparison of Reported BCV-L9 Profiles from HRT-18 Cells.
Williams (133)
Reducing Conditions 
light virions dense virions
Brian
Reducing
conditions
(46, 63, 64) 
Non-reducing 
conditions
St.Cyr-Coats (immunoblot detection) 
Reducing Non-reducing 
conditions conditions
182 172 >200 >200
190 190 190 185
160
109 94.5 - 140 140
120 120 125
110
100 100 100
65 - 65
53 53 52 52 52 52
47 47 46 46
35 35 37 37
31-34 31-34
22-26 22-26 26 26 26-28 26-28
20.5 21
15
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Figure VI. 1. Polypeptide Profiles of BCV-L9 Propagated in 
D2BFS Cells (+ trypsin) or HRT-18 Cells.
Proteins were detected by silver and Coomassie 
staining. 12% acrylamide. Virus in lanes B and 
C was prepared with reducing agent. Lanes E and 
F contained non-reduced virus. Lanes A, D, G - 
molecular weight standards, Lanes B and E - L9 
(HRT-18), lanes C and F - L9 (D2BFS). Arrows 
indicate additional proteins.
> 200-
185-  
160-  
140-
100-
46.
37—  mu******
34-
A B C
Figure VI. 2. Polypeptide Profiles of BCV-L9 Propagated in 
D2BFS Cells and HRT-18 Cells as Detected by 
Western Blotting. Non-reduced. 10% acrylamide. 
Lane A - L9 (HRT-18), lane B - L9 (D2BFS), lane 
C - uninfected D2BFS cells. Arrows indicate 
differences in the profiles.
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Figure VI. 3. Structural Proteins of BCV-L9 Propagated in
HRT-18 Clones as Detected by Western Blotting. 
10% acrylamide. Lanes A-E contained non-reduced 
virus. Lanes F-J contained reduced virus.
Lanes A and F - L9 (D2), lanes B and G - L9 
(3E3), lanes C and H - L9 (3F3), lanes D and I - 
L9 (4B3), lanes E and J - uninfected HRT-18 
cells. Arrows indicate missing bands.
113
*
A B
Figure VI. 4. Structural Proteins of BCV-L9 Propagated in
HRT-18 Clones D2 and 3F3 as Detected by Western 
Blotting. Non-reduced. 10% acrylamide. Lane A 
- L9 (D2), lane B - L9 (3F3). Arrows indicate 
differences in the profiles.
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A B C
Figure VI. 5. Polypeptide Profiles of BCV-L9 Propagated in 
D2BFS Cells in the Presence and Absence of 
Trypsin as Detected by Western Blotting. 
Non-reduced. 10% acrylamide. Lane A - (-) 
trypsin, lane B - (+) trypsin, lane C - 
uninfected D2BFS cells. Arrows indicate 
structural differences.
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Figure VI. 6. Structural Profiles of In Vitro Trypsin-Treated 
and Untreated BCV-L9 Propagated in HRT-18 Cells 
as Detected by Silver Staining. 12% acrylamide. 
Lanes A and B contained non-reduced virus.
Lanes C and D contained virus prepared with 
reducing agent. Lanes A and C - trypsin-treated 
virus, lanes B and D - untreated virus, lanes E 
and F - molecular weight standards.
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Figure VI. 7. Western Blot-Detected Protein Profile of In Vitro
Trypsin-Treated BCV-L9 Produced in Clones 3F3 and 4B3. 
Non-reduced. 10% acrylamide. Lane A - untreated L9 
(4B3), lane B - trypsin-treated L9 (4B3), lane C - 
trypsin-treated L9 (3F3), lane D - untreated L9 (3F3). 
Arrows indicate structural differences.
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Figure VI. 8. Western Blot-Detected Protein Profile of In
Vitro Trypsin-Treated BCV-L9 Produced in Clone 
3F3. Reducing Conditions. 10% acrylamide.
Lane A - uninfected 3F3 cells, lane B - 
untreated L9 (3F3), lane C - trypsin-treated L9 
(3F3). Arrows indicate structural differences.
CHAPTER VII. SUMMARY AND PERSPECTIVES
Turbid plaques consisting of some apparently normal cells are 
produced by BCV-L9 in HRT-18 monolayers. This observation suggests that 
the HRT-18 cell population is heterogeneous and consists of 
subpopulations of cells with different susceptibility to BCV infection. 
Immunofluorescent analysis of these plaques revealed that many cells 
within the plaque do not express viral antigen, indicating that some of 
the cells within the plaque are not infected by virus.
Four HRT-18 cell clones, 3F3, D2, 3E3, and 4B3, were characterized 
according to morphology, growth kinetics, plating efficiency, and growth 
in soft agar. Cell monolayers examined by phase-contrast microscopy 
exhibited distinct cell orientations which produced unique surface 
topographies and patterns within the monolayers. These features were 
consistent and reproducible with subpassage. Giemsa-stained cultures 
revealed some variation in colony development at 24 h, with essentially
confluent monolayers at 7 2 h.
The kinetics of growth were determined from the growth curve of each
clone. The doubling times were distinct for each clone, but the
generation times were similar for clones D2, 3F3, and 4B3. Clone 3E3 
displayed a longer generation time. A saturation density of 
approximately 8 million cells was achieved by clones D2, 3E3, and 4B3, 
but was about 1 million cells fewer for clone 3F3. The plating 
efficiencies of clone 3F3 and D2, 100% and 77%, respectively, were 
significantly higher than those of clones 4B3 and 3E3, which were 50% 
and 33%, respectively. No significant differences were found in the 
cells' ability to form colonies in soft agar, and efficiencies of 23%, 
17%, 17%, and 15% were found for clones 3F3, 4B3, 3E3, and D2,
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respectively. The ability to form colonies in soft agar indicated that 
all clones had transformed characteristics.
The growth kinetics of clone 4B3 closely resembled those of the
HRT-18 parent cells at 55th passage. However, clone 3F3 acted most like 
the HRT-18 parent cells at low passage (122). This finding may 
represent the dominant influence of one cell type over the others in the 
parent population at different passage levels.
HRT-18 cell clones were established by limiting dilution in an 
attempt to isolate cell types which were either refractory or highly 
susceptible to BCV infection. The clones displayed differences in the 
type and degree of cytopathic expression when infected with BCV strain
L9. Clone 3F3 produced extensive CPE, while clones D2 and 3E3 produced
moderate CPE. In all three cases cytopathic changes included 
cytoplasmic vacuolization and cell fusion. In contrast, only mild CPE 
occurred in infected clone 4B3, with no detectable cell fusion.
Based on these data it was concluded that the four HRT-18 clones are 
distinctly different cell populations. The basis for their differing 
susceptibility to BCV infection was not determined in this 
investigation.
The characterization of the HRT-18 cell clones could be expanded to 
include other parameters. For instance, the nucleic acid content of the 
clones at 24, 100, and 124 h after seeding is presently being examined 
by flow cytometry to assess putative differences between clones. The 
lack of cell fusion in BCV-infected clone 4B3 in the presence and 
absence of trypsin may reflect the cells' inability to fuse rather than 
the inactivity of the viral fusion factor. The components of the plasma 
membrane contribute to a cell's ability to fuse (109,110,111,112).
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Therefore, analysis of the biochemical make-up of the plasma membrane of 
clone 4B3 in comparison to clone 3F3, which readily fuses when infected 
with BCV, would be useful in determining a possible influence of the 
cell membrane on the cells' ability to fuse when infected with BCV.
The effect of the virus strain, host cell, and trypsin modification 
on the cytopathic expression and plaque development of bovine 
coronavirus was analyzed. HRT-18 parent cells, HRT-18 clones 3F3, D2, 
3E3, and 4B3., and D2BFS cells were used to assay the growth of five wild 
type BCV strains and strain L9. All virus strains replicated in HRT-18 
cells, inducing cell fusion to different degrees. D2BFS cells were 
non-permissive to all wild-type BCV strains, but L9 replicated in these 
cells. Trypsin enhanced the cytopathic expression, activating cell 
fusion in D2BFS cells. The CPE varied in L9-infected HRT-18 clones. 
Trypsin enhanced CPE and cell fusion in clones 3F3, D2, and 3E3, but not 
in clone 4B3. The plaque development of strain L9 varied in the four 
clones. Plaques were readily produced in clone 3F3, and these were 
dramatically enhanced by trypsin. The diameter of the plaques increased 
significantly, plaques became less turbid and more distinct, and they 
developed more rapidly in the presence of trypsin. Plaques developed 
less efficiently in the other three clones, with trypsin enhancing 
plaque development only marginally. No plaques were produced in clone 
4B3 cells infected with wild-type virus strains, but plaques developed 
in clone 3F3. Strains Meeker, Miller, Fisher, Calf 50, and LY-138 
produced different plaque phenotypes in clone 3F3, and in all cases the 
plaques were enhanced by trypsin.
The effect of trypsin on the infectivity of BCV-L9 propagated in 
different host cells was analyzed. The virus was propagated in the
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presence and absence of trypsin, and PFU:HA ratios at virus dilutions 
“2 *"610 -10 were compared. The infectivity of the virus was enhanced to
infinite proportions at high dilutions in both D2BFS cells and HRT-18 
cells, but the increase was evident at a 100-fold lower dilution in 
D2BFS cells. Limited trypsin enhancement of infectivity occurred in 
clones D2, 3E3, and 3F3 which displayed PFU:HA ratios in the presence or 
absence of trypsin of 2:1, 3:1, and 5:1, respectively. Trypsin caused a 
decrease in infectivity of L9 propagated in clone 4B3. Additionally, 
strain LY-138 was assayed in HRT-18 parent cells. An infectivity 
increase of less than 1 log unit was obtained at the highest dilution of 
virus. These data indicate that the infectivity of BCV was affected by 
the strain of virus, host-dependent factors, and by trypsin.
Host cell-dependent differences in the non-reduced polypeptide 
profile of BCV-L9 were identified. A 62 Kd protein was evident by 
silver stain from L9 propagated in D2BFS cells with trypsin. This 
protein was not detected in L9 (HRT-18). The protein may be a 
cell-specific viral protein or a trypsin cleavage product. The 62 Kd 
protein was not detectable by Western blot. A 46 Kd protein was present 
in L9 produced in all cell types except clone 4B3. L9 propagated in 
clones 3F3, 3E3, and 4B3 had a doublet of 110 and 100 Kd proteins, but 
only a single 100 Kd band was detected in L9 (D2). The two species may 
represent glycosylation isomers, such as those found at 26 Kd, or 
different cleavage products, but their relationship is undetermined.
The 140 Kd protein was reduced to a 65 Kd species, an observation 
previously reported by Hogue and coworkers (46). Additionally, the 185 
Kd protein migrated as a 190 Kd species, and the 100 Kd protein migrated 
as a 95 Kd species in the presence of reducing agent. Changes in the
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electrophoretic migration of these proteins may reflect intrachain 
disulfide bonding as discussed in the previous chapter. The 18, 20, and 
23 Kd molecules were converted to a 20-23 Kd cluster under reducing 
conditions. The relationship of reduced and non-reduced proteins was 
not discernable by Western blot. The antigenic configuration was 
probably altered by reducing conditions making the reduced products less 
antigenic in the blotting procedure.
L9 propagated in D2BFS cells with and without trypsin were compared 
under non-reducing conditions by Western blotting. Notable differences 
in the two profiles included the following: The 185 Kd protein was
present as a broad band in virus produced without trypsin, but the 
protein was nearly inapparent in L9 propagated with trypsin. Coincident 
with the disappearence of the 185 Kd species was a significant increase 
in the 100 Kd protein. The precursor-product relationship of the two 
species must be examined either by tryptic peptide mapping or with 
monospecific antiserum against the 185 Kd species. Since L9-infected 
D2BFS cells fuse only in the presence of trypsin, cleavage of the 185 Kd 
protein to the 100 Kd form probably activates the fusion factor, but 
other undetected cleavage products, such as the 62 Kd protein, may be 
involved in cell fusion. In addition, the 31-34 Kd cluster was present 
as a single 34 Kd protein in the presence of trypsin, indicating that 
these proteins are an external component since they were accessible to 
trypsin.
Trypsin cleavage products of L9 propagated in HRT-18 cells or D2BFS 
cells with trypsin were evident in silver-stained gels only under 
reducing conditions. Evidently, the cleaved proteins were held intact 
by disulfide bridges. Trypsin-dependent bands of 93, 71, and 62 Kd
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were identified in the L9 (D2BFS + trypsin) preparations, and a 90 Kd 
trypsin-dependent band was obtained from L9 (HRT-18). The 93 and 90 Kd 
species are possibly the same protein which migrated differently on 
different gels. Trypsin also acted on the 20-23 Kd cluster seen in the 
L9 (HRT-18) preparation, converting it to the 19-23 Kd range.
In vitro trypsin-treated L9 obtained from clones 4B3 and 3F3 were 
compared to untreated virus. Changes in the polypeptide profile of L9 
(4B3) were not detected. The 46 Kd protein was present in untreated L9 
(3F3) but absent in trypsin-treated virions. Concomitantly, a 25 Kd 
protein appeared in the treated preparation. The precursor-product 
relationship of the 46 and 25 Kd proteins must be analyzed before a 
correlation between the two species can be determined.
At least eleven structural proteins of BCV-L9 were identified.
These proteins had approximate molecular weights of 185, 160, 140, 125, 
110, 100, 52, 46, 37, 31-34, and 26-28 Kd, but the profile of BCV-L9 
showed differences depending on the host cell used for propagating the 
virus and the detection system employed. Hogue et al (46) and King and 
coworkers (63,64) identified high molecular weight glycoproteins of 190, 
140, 120, and 100 Kd which are surface proteins. It was our experience 
that when the protein concentration was high on the gels or when poor 
separation of the proteins occurred, then the 160 Kd protein was not 
distinguishable from the 185 Kd protein; the 140 and 125 Kd proteins
appeared as a single broad band that migrated at 140 Kd; and the 110 and
100 Kd proteins were not resolved and appeared as a single, broad 100 Kd 
band. Consequently, detection of all the viral proteins required an
optimal protein load and running conditons.
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The high molecular weight proteins identified by Williams (133) can 
not be accurately compared to our profile since Williams performed his 
experiments under reducing conditions. The two virus phenotypes 
observed by Williams were not analyzed separately in our 
experimentation. Rather, our analysis represents a composite profile of 
the two BCV phenotypes, probably contributing to the greater complexity 
of our virus profile.
David Brian's group (46,63,64) identified the 140 Kd protein as the 
hemagglutinin and suggested that the 52 Kd and 26 Kd species are 
nucleocapsid and matrix proteins, respectively. Using anti-pp 52 
antiserum in immunoblots, these investigators detected a 160 Kd species 
in some BCV preparations. They assumed that the protein represents a 
triraer of pp 52 (46). The functions of our additional proteins are 
undetermined. The location and functions of the constituent viral 
proteins could be determined by in vitro enzymatic iodination of intact 
and disrupted virions. With intact virions, only external proteins 
would be iodinated, while internal proteins would also be labeled using 
disrupted virions (63).
While it was important to examine the reduced profile of BCV to 
determine the subunit structure of the virus, the non-reduced virus is 
the form of virus which causes disease in the natural infection. 
Iramunoblot detection of the non-reduced viral proteins was conducted 
using antiserum obtained from an experimentally infected calf. This 
technique allowed the identification of the immunogenic viral proteins, 
and provided information about the form of virus presented to and 
recognized by the host humoral immune system. It is possible that other 
viral proteins were not detected due to a loss of antigenicity through
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heat denaturation, SDS-treatment, transfer to nitrocellulose, or other 
procedures used to separate and analyze the proteins.
A hypothetical model of the structure of BCV-L9 is proposed based on
the data obtained from these investigations and those previously 
reported (46,63,64,133) (Fig. VII.1). This model depicts the viral 
proteins identified under non-reducing conditions, since this form of 
virus is the infectious agent in nature.
In the infectious form the 185 Kd peplomeric protein is cleaved to 
100 Kd. This study has revealed that processing of the 185 Kd protein 
occurs either by cellular proteases or by trypsin. HRT-18 cells and 
clones 3F3, 3E3, D2, and 4B3 were capable of efficient cleavage of the 
protein. Conversely, the 185 Kd protein was only partially cleaved in 
D2BFS cells, and trypsin was required for complete cleavage of the 
protein. As a result, cell fusion occurred in BCV-L9-infected D2BFS 
cells only in the presence of trypsin.
Brian's group (46,63,64) proposed that the 140, 120, and 100 Kd 
proteins were surface glycoproteins. Our 110 Kd molecule is probably a
peplomeric protein as well. The protein may represent an additional
cleavage product of the 185 Kd species, or the 110 and 100 Kd bands may 
be glycosylation isomers.
The nucleocapsid protein of BCV-L9 has a molecular weight of 52 Kd. 
Hogue and coworkers (46) suggested that the 160 Kd protein is a trimer 
of this species since it cross reacts with monospecific antiserum 
directed against pp 52. The 26-28 Kd cluster presumably represents 
glycosylation isomers of the matrix protein. The 31-34 Kd cluster may 
also comprise the matrix.
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The 140 Kd protein consists of disulfide-linked subunits of 65 Kd 
(46,63,64). Our data indicates that intrachain disulfide linkages are 
present in the 185, 100, 26-28, and 31-34 Kd proteins.
Undefined proteins of 46 and 37 Kd were identified. The 46 Kd 
protein is probably an external protein since it was cleaved by trypsin 
in some preparations. Trypsin had no effect on the electrophoretic 
migration of the 37 Kd species. Although the data are insufficient to 
accurately position these proteins, they have been incorporated into the 
hypothetical model.
There is tremendous diversity in the recognized polypeptide 
composition of different coronaviruses, and the complexity of these 
viruses is emerging. For instance, three structural proteins were 
originally identified for MHV, but four proteins are now accepted. A 
number of coronaviruses are considered to consist of four proteins 
including DVIM, HCV-OC43, TGEV, and others (41,46,120), while up to nine 
proteins are found with HECV-24 and 35 (5). As demonstrated in these 
investigations, the structural composition of bovine coronaviruses is 
far from settled. Inevitably, the accepted profiles of many 
coronaviruses will change as experimentation progresses.
The data presented in this manuscript have significant implications 
for the continuing study of coronavirus-host relationships, virulence of 
BCV, and prevention of disease. Cell types with different 
susceptibility to BCV infection were identified. Varied cytopathic 
expression of the virus in the HRT-18 clones and D2BFS cells were 
correlated to differences in the structural profile of the virus.
Proteins which potentially contributed to cytopathic expression and 
infectivity of the virus were identified.
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The different cell types could be further examined to identify 
cellular factors, such as proteases, which contribute to the production 
of infectious virus. At the same time, cellular resistance factors 
could be determined.
Trypsin enhanced the CPE and infectivity of BCV and altered the 
polypeptide profile of the virus. Since trypsin is a constituent 
digestive enzyme of the intestinal tract, it may influence BCV virulence 
in natural infections. If this is the case, inhibition of trypsin 
action in the gut may be a useful method for prevention of infection in 
newborn calves. However, it would be necessary to devise such a 
treatment without disrupting the digestive process of the animal.
Wild-type BCV strains displayed differences in CPE and plaque 
formation with and without trypsin. These viruses also have some 
differences in their polypeptide profiles (132). These strains may vary 
in their ease of processing to the infectious form by trypsin or 
cellular proteases. This observation possibly reflects a viral 
virulence factor in cases of natural infection.
The structural profile of BCV-L9 was determined, revealing that BCV 
is a complex virus. Knowledge of the prevalence, stability, and 
antigenicity of the viral proteins is important in the development of 
viral vaccines - especially when developing inactivated, recombinant, or 
synthetic peptide vaccines.
Cleavage of the 185 Kd precursor protein to the 100 Kd form 
correlated to activation of cell fusion and enhanced viral infectivity. 
Therefore, the 100 Kd protein is most likely the viral fusion factor, 
the protein responsible for cell to cell spread of infection.
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Figure VII. 1. Hypothetical Model of Bovine Coronavirus Strain L9
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